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ABSTRACT 
 
With the rapidly increasing interest in the field of glycomics, which is the 
comprehensive study of the roles carbohydrates play in a living system, urgent need for 
developing quick and highly selective carbohydrate sensors is growing. The boronic acid 
group, with its electron-deficient structure (6 valence electrons with an open shell), acts 
as a Lewis acid with high intrinsic affinity towards Lewis bases such as fluoride, cyanide 
and hydroxyl groups. Specifically, formation of a 5- or 6- membered ring between the 
boronic acid moiety and a1,2- or 1,3-diol in aqueous solution has been fully explored as 
a strategy of carbohydrate sensor design. Along this line, those binders were termed as 
“boronolectins” because of their similar functions as lectins.  
One challenge in developing boronic acid-based carbohydrate sensors is to 
enhance the discriminating ability among various carbohydrate analytes with diverse 
building blocks and complex linkage patterns. One approach is using polypeptide or 
 oligonucleotide as a backbone or scaffold with functionalized boronic acid moiety to 
create a molecular library, and then selecting binders with favorable properties. 
The work presented here includes three general research parts: synthesis of a 
naphthalimide-based boronic acid-conjugated thymidine triphosphate (NB-TTP), 
fluorescence property studies of NB-TTP incorporated DNA (NB-DNA), and cellular 
imaging studies using NB-TTP: 
1) 4-Amino-1,4-naphthalimide (Nap) was chosen as the fluorophore because of its 
relatively long excitation and emission wavelengths, and stability. The synthesis of 
naphthalimide-based boronic acid (NB) followed similar route as previously published 
work. Tethering of boronic acid moiety and TTP was accomplished through 
Cu(I)-catalyzed azide-alkyne cyclization (CuAAC), known as click chemistry. The 
synthesized NB-TTP showed fluorescence enhancements at long wavelength (λem: 540 
nm) upon sugar addition.  
2) NB-TTP was incorporated into DNA through Klenow fragment-catalyzed primer 
extension reactions. Different DNA sequences were designed with varying number and 
spacing for NB-TTP incorporation. The preliminary study provided certain insight into 
several factors that affect the fluorescent properties of different NB -DNA. 
3) NB-TTP was added into Hela cell culture medium to study its cell imaging 
properties. With the observation under fluorescent microscope, it was demonstrated that 
NB-TTP showed good cell membrane permeability and significant accumulation in cell 
nucleus. 
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1. INTRODUCTION 
1.1 . Glycomics study and natural carbohydrate sensors  
With the completion of the Human Genome Project and the mapping of 
approximately 20,000-25,000 genes in the human genome,1-3 the world is entering into a 
post-genomics era of investigating how genes function in a coordinated fashion in vivo 
and in response to outside environment. It is well known that after transcription and 
translation from the genomic DNA sequences, the expressed proteins or peptide 
sequences sometimes undergo further modifications (post-translational modification, 
PTM) in order to gain full function properly.4-7 Glycosylation, the attachment of 
oligosaccharide moieties to the protein, is perhaps the most complicated form of 
PTM.8-10 In fact, the differences contributed by the various glycoforms are so significant 
that the microdiversity of proteins created by glycosylation can determine their functions 
and properties.11-15 Collectively, the vast diversity of glycans arises from its non-template 
driven biosynthetic routes, a lack of proof-reading machinery, and a large number of 
tissue-specific isoforms of glycosyltransferase and glycosidase.16-17 Differences in 
sequence, composition and branching patterns also provide the chemical basis for the 
structural complexity of glycans. Such complexity rivals or exceeds that of proteins and 
nucleic acids. On one hand, the inherent chemical heterogeneity and structural diversity 
makes it convenient for cells to coordinate together and be individual and specific in the 
whole body context. On the other hand, it also creates a great challenging scenario in the 
research field of glycosylation. Thus, there is an urgent need for developing tools to 
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detect and differentiate so many different forms of glycans. Currently, the word “glycan” 
refers to a general term including oligosaccharides, polysaccharides and 
carbohydrates.17 The term of “glycomics” also emerged correspondingly, which is 
defined as the comprehensive study of the biological roles glycans play in living 
organisms, as in parallel with terms like genomics, proteomics and lipidomics. 
1.1.1 Brief introduction of glycan structures 
Briefly, there are nine monosaccharides used by mammals in enzymatic glycosylation 
processes. These are galactose, glucose, glucuronic acid, fucose, mannose, 
N-acetylgalactosamine, N-acetylglucosamine, sialic acid and xylose (Figure 1.1).17 For 
glycans on cell membranes or extracellular compartment in the forms of glycoproteins 
and glycolipids, their assembling is through the Golgi apparatus where the glycan 
oligomers elongate and branch.12,18 There are three major glycosylation patterns of 
protein: O-glycan, N-glycan and glycosaminoglycan. Specifically, N-glycans are attached 
to the asparagine residues in the Asn-X-Ser/Thr motif of proteins.19-21 O-Glycans are 
linked to either Ser or Thr residues.19,22 Glycosaminoglycans are also Ser or Thr 
anchored but in linear instead of branched, and often highly sulfated oligo-forms.23-25 
Glycosylation on lipids is in the form of sialic acid-bearing gangliosides.26-27 Besides 
those glycosylations that happen through the Golgi apparatus secretory pathways, many 
cytoplasmic and nuclear proteins are glycosylated by N-acetylglucosaminidase in 
cytoplasm. N-Acetylglucosamines attached to Ser or Thr residues (O-GlcNAc) of those 
proteins are found to be a very important PTM regulated for many mammalian cell types’ 
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viability, probably as nutrient sensors or protein turnover regulation factors.28-31 Again, all 
the glycosylation patterns with α orβanomers linking through 1,2 (donor) → 2,3,4,6 
(acceptor) glycosidic bonds contribute to a repertoire of tremendous number of glycan 
structures.17  
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Figure 1.1. Monosaccharides used in mammalian enzymatic glycosylations  
 
1.1.2 Brief introduction of glycosylation functions 
Glycosylation in animal body functions is important. For example, in transgenic mice 
with GlcNAcT-1 glycosyltransferase deficiency, the embryos showed severe defects in 
the cardiovascular system and other morphogenic abnormalities.32-33 In general, there 
are several biological processes that involve glycosylation. For example, cell-cell 
adhesion mediated by glycan-protein interactions is critical for trafficking lymphocytes, 
neutrophils, CD4+ T cells, natural killer cells and other immuno-responsive cells to the 
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site of inflammation;34-37 the mammalian immunoreaction is directed by molecular 
recognition mechanisms including a key fucose linkage on sialyl-Lewis X 
oligosaccharide;38 self/non-self recognition through discrimination of pathogen glycans 
by mammalian cells is responsible for the initiation of some immunoreactions;39-40 
pathogen-associated molecular patterns (PAMP), once recognized and bound, can 
initiate phagocytosis by macrophages to clear up the invading organisms.41-45 Glycan 
recognition is also responsible for the body’s metabolism regulation, such as turnover of 
endogenous glycoproteins. One case in point is the hepatic asialoglycoprotein receptors 
(or hepatic binding proteins, HBP), which can bind to and internalize the glycoproteins 
with fewer or without any sialic acid linkages.46 In mice with decreasing thrombosis 
resulting from defective sialytransferase expression, both platelets and the von 
Willebrand factor (vWF) glycoproteins are targets for asialoglycoprotein receptors.47 
Moreover, some glycosylation recognitions are involved in cellular receptor activation 
and signal transduction processes. For example, specific heparan sulfate, as one kind of 
glycosylaminoglycans, can bind to fibroblast growth-factor receptors and induce receptor 
dimerization and activation.48 It is also found that some morphogenesis and 
organogenesis in early embryo stages can be regulated through 
glycosylaminoglycan-receptor binding.49 Of course, listing all the examples of 
glycosylation importance will be laborious work and not practical. Illustrating a few 
examples above helps to highlight the meaning and need for developing tools for glycan 
sensing and study. 
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Given the importance of glycosylation in normal mammalian body functions, it is 
conceivable that abnormality of certain glycosylation patterns could result in dysfunction 
or even disease of human body. For example, the lack of dolicol-oligosaccharide 
precursor resulting in a decrease in N-glycosylation frequency is found to be responsible 
for congenital disorders of glycosylation (CDG) syndromes of children, many of which 
are discovered especially in their early life years.50-52 I-cell disease, resulting from the 
failure of mannose-6-phosphate modification of N-glycan in the Golgi body, causes a 
protein storage disorder, due to the lack of trafficking signal of hydrolase into 
lysosome.53-54 Furthermore, unusual glycosylation patterns serve as good indicators for 
specific diseases such as cancer and serve as biomarkers in clinical diagnosis.55-60 In 
one case, elevated T-antigen levels (truncated O-glycan) were correlated with the 
prognosis of low survival rate of certain cancer patients.14,61 Another example is the 
prostate cancer antigen (PSA) from tumor cells, which contains a higher level of fucose 
and absence of sialic acid compared with PSA from normal cells.62-65 Also, different 
glycosylated forms of hCG can be diagnostic biomarkers for cancer, Down syndrome, or 
pregnancy failure.66-67 Specifically, hyperglycosylated hCGs (hCG-H, also known as 
invasive trophoblast antigen-ITA), are very different from normal hCG (human chorionic 
gonadotropin) in terms of both functions, origins, and glycosylation paterns. While 
hCG-H is essential for successful human implantation, it is also an invasive promoter in 
choriocarcinoma.68 One last but not least example is human RNase 1, which has 
completely different glycosylation patterns when secreted by pancreatic tumor cells 
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compared with those by normal cells.58,69-70 For a more comprehensive compiling of 
glycan-based biomarkers, some excellent reviews are recommended.71-73 However, 
even with those well-documented glycosylation related diseases, the discovery process 
is more serendipitous than well-planned.17 Commonly used protein separation methods 
through isoelectric focusing and electrophoresis are not able to catch most glycosylation 
defects. Thus, developing tools that can primarily focus on the glycosylation 
microdomain (sweet spots) should have great meaning and implication in clinical 
practice. 
1.1.3 Conventional tools and methods for glycosylation studies 
Conventional chemistry analytical approaches, such as mass spectrometry,74-79 
HPLC80-81 and NMR,82-84 have been used together with computational informatics as an 
integral method for glycan primary structure characterization.16,85-86 As powerful as those 
essential tools are, they suffer from the shortcomings of time consuming, and the need 
for advanced expertise and large sample amounts (for NMR). Besides, analysis of the 
glycan moieties using those methods requires removal of the saccharides from proteins 
and seperate characterizations. Due to the inherent heterogeneity nature of glycans, 
systematic analysis of a large number of glycans demands a more efficient approach.  
The above-mentioned proteins that bind to N- or O-glycans and mediate various 
biological processes are generally termed glycan-binding proteins (GBP). So far, three 
major classes of natural GBPs have been identified in mammalian system: C-type lectins, 
siglecs and galactins.9-10,16 The C-type lectins are so named because of their 
7 
 
 
requirement of Ca2+ for proper functions.87-88 C-type lectins are further divided into three 
sub-classes: endocytic lectins, collectins and selectins. Previously discussed hepatic 
binding proteins (HBP) are the prototype of endocytic lectins, specific for 
galactose/N-acetylgalactosamine moiety.46,89-90 Endocytic lectins are all transmembrane 
proteins with extracellular carbohydrate recognition domain (CRD).88 In contrast, 
collectins are soluble proteins with a cysteine-rich amino terminal and a CRD carboxyl 
terminal.91-92 Mannose-binding proteins (MBP A and MBP C) are typical examples of 
collectins.93-96 The third subclass, selectins are so named because of their mediation in 
selective contact between cells. Three members of selectins, E-selectin, P-selectin and 
L-selectins, are all membrane bound proteins with CRD located at amino terminal 
part.97-101 In total, there are hundreds of lectins identified and characterized, among 
which about 60 of them are commercially available from companies like Sigma-Aldrich 
and Fisher Scientific.71 Due to the flexibility around glycosidic linkage, oligosaccharides 
exist with highly dynamic conformations. The lectin-glycan binding affinity is quite 
structure-dependent so that saccharides with different chemical compositions but similar 
topographic properties can bind to the same lectin.88 In contrast, different lectins for the 
same saccharide could focus on separate regions of the saccharide structure. However, 
once bound by lectins, specific conformation of the glycan is locked and fixed and the 
rotational freedom around glycosidic linkage is reduced. Thus, lectins bind saccharides 
in a reversible and specific way, but they all have cross-reactivity issues.71,88 Different 
from C-type lectins, siglecs are a subgroup of immunoglobulin superfamily, termed I-type 
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lectins.102-103 The N-terminal of siglecs specifically recognizes sialic acid-containing 
ligands. The third type of GBPs, galectins are so named because their selective affinity 
towards galactose-containing ligands on cell-surface.104-106  
All three types of GBPs are involved in previously discussed cell-cell adhesion, cell 
trafficking and signal transduction processes through target glycan bindings. Among 
them, lectins are the most widely used tools in glycan 
research.34,37,44,60,88,91-92,99,102-103,105-110 Binding between lectin and carbohydrate happens 
on the shallow cavity of lectin surface and primarily relys on hydrogen bond formations 
and hydrophobic interactions.71,88 Thus, single lectin-glycan interaction is very week with 
Kd at the mM level. Tight binding is achieved through cooperative multivalent interactions 
of lectin towards oligosaccharides (Kd to μM range),111-112 while lectin-monosaccharide 
interaction remains at the same level. Application of lectins in glycosylation research has 
been achieved in recent years through a lectin-microarray method.108-110,113 Basically, 
different types of selected lectins are immobilized on the array surfaces and analytes 
with fluorescence labeling are applied on the microarray. Through analyzing the binding 
profiles generated on the arrays, each glycosylation pattern has one corresponding 
fingerprint profile. Through such method, general glycan information such as N- or 
O-glycosylated form, mannose and fucose content and sialylated level could be acquired. 
Furthermore, even real-time monitoring of glycosylation pattern changes was achieved 
using this approach.109 
Given the efficiency of lectin microarray in glycan detection, the technique is still 
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limited by the availability of lectins. First of all, only about 40 commercially available 
lectins can be obtained conveniently, compared to hundreds and thousands of glycan 
targets are on the list of being analyzed. Second, the cost is still much higher using 
biological generated lectins than using usual chemically synthesized sensors. 
1.1.4 Conclusion  
In general, carbohydrates are very important in glycosylation modification of proteins. 
Acurate detection and characterization of those glycans have great implication in terms 
of both fundamental biological research and clinical diagnostic applications. However, 
the complexity and numerous varieties of the carbohydrate analytes constitute an inviting 
challenge for people to develop rapid and efficient research tools in area of carbohydrate 
recognition. Lectins as natural carbohydrate binders showed great promise in their high 
affinity and somehow selectivity towards oligosaccharides sensing. However, in order to 
address the issues of their high cost, limited availability and certain degree of cross 
reactivity, there is an urgent demand for developing artificial lectin-mimetics that are low 
in cost, easy to make and highly selective. For such purpose, great amount of efforts 
have been carried out in developing synthetic lectin-mimetics using chemical 
approaches, among which one specific class is the boronic acid-based carbohydrate 
sensor utilizing the intrinsic affinity of boronic acid towards carbohydrate diols. 
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1.2 Boronic acid: a powerful tool to detect carbohydrates 
1.2.1 Brief introduction of boronic acid chemistry 
As introduced in the previous chapter, the importance of glycomics studies requires 
the development of novel powerful tools to assist and complement currently using 
biological approaches. Under the “biology-driven chemistry” impetus, great effort has 
been undertaken to develop artificial sensors for carbohydrate. Besides the need in 
glycosylation research, those sensors may even be further applied for clinical diagnostic 
and therapeutic purposes. In terms of their functions, those sensors act as lectin mimics. 
In general, there are two chemical design strategies:  boronic acid-based and 
non-boronic acid-based sensors. The boronic acid-based lectin mimics using the strong 
and reversible interactions between boronic acids and hydroxyl groups as recognition 
moieties are termed “boronolectins”.114 In contrast, most of the non-boronic acid-based 
lectin mimics rely on hydrogen bond, hydrophobic and ionic interactions in building up the 
intrinsic affinity.71,115-116 It should be noticed that in an ideal application situation, the 
carbohydrate sensing should be best performed in an aqueous environment. Most of the 
non-boronic acid lectin mimics designed so far only function under aprotic solvent 
system.116-118  
Since for chemosensing purpose the solvent system is not a major issue, it is 
understandable since those interaction studies could provide insightful information about 
non-covalent interactions between carbohydrates and sensors, which is the strategy that 
nature adapts in lectin-glycan binding processes. One noticeable exception of them is 
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the elegant work by the Davis group. In this case, a binding cavity was created to 
accommodate sugar moiety with parallel aryl rings as the roof and floor for hydrophobic 
interactions, and with four amide linkers as pillars for hydrogen bond interactions (Figure 
1.2).116,119 Thus, the sensor designed spatially complement saccharides possessing axial 
CH groups (CH-π interaction) and equatorial hydroxyl groups (hydrogen bond interaction) 
(Scheme 1.1). Then dodecacarboxylate side chains were linked to sensor to provide it 
with good solubility for entering into the aqueous phase.120 The sensor and 
β-N-acetyl-D-glucosaminyl (β-GlcNAc) have a association constant of 630 M-1,121 which 
was strong enough to rival natural β-GlcNAc lection, wheat germ agglutinin (WGA). 
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Figure 1.2 Non-boronic acid water-soluble lectin mimics by the Davis Group120  
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Scheme 1.1 Proposed interaction model between sugar and non-covalent receptors 
by the Davis group116 
 
Meanwhile, there are many water soluble boronlectins designed, which have promise 
for potential biological applications in the future. The nature of biological studies and 
clinical diagnostics makes water solubility a primary requisite of sensing tools.  Due to 
the widely spread effort in using boronic acid as a carbohydrate recognition motif from a 
great many active labs including that of Strongin, Shinkai, Czarnik, Anslyn, Lavigne, 
Heagy, Duggan, Hall, Asher, James, Wang, Lakowicz, Geddes, Norrild, Hindsgaul, 
Singaram, Tao, Lowe, Eggert, Smith, Okano, Taylor, Takeuchi, Ishihara, Katterle, 
Sporzynski, Freund, Mattiasson, Yoon, Scheller, Tuncel, Anzai, Houston etc,122-123 it 
would be necessary to get a comprehensive understanding of the chemistry nature of 
boronic acid first. 
The boron atom of boronic acid in its neutral form is in sp2 hybridization status with 6 
valence electrons forming 3 pairs in a trigonal plane and a vacant p orbital perpendicular 
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to it. Thus, the electron deficiency nature of boronic acid makes it a ready lone pair 
electrons acceptor to fill its open shell and achieve a stable octet state. Because of such 
unique electronic structural property of the boron atom, boronic acid has a high tendency 
to react with a Lewis base such as hydroxyl, amino, and carboxylate groups.124-131 
Boronic acids are also known to bind with simple Lewis bases such as fluoride132-135 and 
cyanide.136-137 All these features have stimulated great interest in utilizing boronic acid as 
a key functional group for designing receptors and sensors for carbohydrates,138-143 
hydroxyacids,144-147 amino alcohols,127,148-149 cyanide,136-137 and fluoride.132-135,150 
Among all the boronic acid sensor applications, we are particularly interested in the 
carbohydrate sensing area. In fact, boronic acid’s specialty in the carbohydrate 
recognition field is widely acknowledged by chemists, especially due to its unique high 
affinity towards 1,2- or 1,3- carbohydrate diols. For a detailed discussion of boronic 
acid-carbohydrate complex formation, it will be helpful to begin with an illustration of 
several features of the boronic acid-diol interaction. Firstly, the acidity of a boronic acid 
arises differently from that of a conventional BrØnsted acid, which releases a proton. 
Taken phenylboronic acid (PBA, 1, Scheme 1.2) as an example. In a protic solvent such 
as water or alcohol, solvent molecules will first react with boronic acid by donating lone 
pair electrons to occupy the boron p orbital, which converts the hybridization state of B 
from sp2 to sp3. The coordination complex will then release one proton to form an anionic 
tetrahedral phenylboronate (2, Scheme 1.2). Since the deprotonation of the boronic acid 
hydroxyl group is much harder (higher pKa), the acidity of a boronic acid actually results 
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from its Lewis acidity per se. In an aprotic solvent, boronic acids act as a pure Lewis acid. 
For this reason, boronic acids are frequently used as Lewis acid catalysts and chelating 
agents for reaction controls in organic synthesis.151 Secondly, the boronic acid is 
transformed to its corresponding boronic ester once it reacts with carbohydrate diol (3, 
Scheme 1.2). The driven force is partially due to the 5- or 6- membered ring formation, 
depending on whether it’s 1,2- or 1,3- diols respectively. It should be noticed that the 
acidity of the boronic ester still remains due to the existence of the boron open shell. The 
boronic ester can react with a protic solvent molecule, release a proton, and generate 
the boronate ester anion (4, Scheme 1.2) much the same way as a boronic acid. 
Determined by the dihedral angles and ring strains of the formed complex, boronic ester 
acidity is also affected by the stabilizing energy of sp3-boron accordingly. In most of the 
cases, boronic acids are more readily binding towards linear diols and diols on 
five-membered rings than diols on six-membered rings.71 Exceptions do exist such as 
pinandiol,152-154 which is a six-membered ring and binds boronic acid very tightly. The 
key is still the dihedral angle. Smaller O-C-C-O dihedral angles favor binding by driving 
the reaction equilibrium to forming more stable anionic boronate esters with tetrahedral 
geometry, making boronic esters usually more acidic than boronic acids. This also 
partially explains the reason for the high affinities that catechols display towards boronic 
acid. One useful method for determining boronic acid-diol binding constant using Alizarin 
red S (ARS) was developed by our group based on competitions,155 which will be 
discussed later. Thirdly, because of the intrinsic Lewis acidity of both boronic acids and 
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boronic esters, it is conceivable that the boronic acid-carbohydrate binding affinity will be 
affected by boronic acid/diol pKa values and solution pH. Most of the time, low boronic 
acid pKa values and high pH conditions are commonly believed to favor binding.126 
However, this is not always the case. Optimal binding conditions involve the interplay of 
the pKa values of the boronic acid and diol, solution pH, and the nature and concentration 
of the buffer solution.114,126 It was found that the optimal binding pH is often between the 
pKa values of the boronic acids and diols. For example, the optimal pH for the binding 
between ARS and a phenyl boronic acid is close to or below 7.4,126,155 while in other 
cases of boronic acid-carbohydrate binding the preferred binding pH is within basic 
condition. Beside those, several other factors such as solvent system, buffer composition, 
temperature and steric hindrance can also affect intrinsic affinities of diols for a boronic 
acid. 114,125-126  
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Scheme 1.2 Binding of phenylboronic acid with a diol 
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From the above discussions about boronic acid-diol binding, it is easy to see that with 
all the factors affecting the binding process, not all boronic acids have the same affinity 
toward a given diol and not all diols have the same affinity for a given boronic acid. Thus, 
for the design of boronic acid-based carbohydrate sensors, taking multiple factors as a 
whole picture into consideration with detailed analysis is required for building binders of 
high intrinsic affinity and selectivity with the best chance for success. For measuring and 
comparing the boronic acid-diol binding affinities, binding constant Ka or dissociation 
constant Kd is often used. However, in this case, binding constant Ka is really referred to 
as the apparent overall binding constant, Kapp, which does not considerate the ionization 
states of boronic acids or boronic esters (Scheme 1.3).125-126 From the overall binding 
equation, the real binding event happens among all four molecular forms as trigonal 
boronic acid 1, tetrahedral boronate 2, trigonal boronic ester 3 and tetrahedral boronate 
ester 4 (Scheme 1.3). Using either binding constant Ktrig (equilibrium constant between 
the trigonal forms of boronic acid and boronic ester) or Ktet (equilibrium between the 
tetrahedral boronate form and boronate ester) will not be representative enough to 
describe the process in a general way.114 To simplify the situation but not leaving out the 
essential information, an overall equilibrium to represent the binding between a 
phenylboronic acid and a diol is used without digging up the exact ionization status 
distribution of all forms. After all, Kapp is directly related to the binding/dissociation 
equilibrium and informative enough for binding affinity evaluation. 
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Scheme 1.3 Overall binding equilibrium of phenylboronic acid with a diol 
In conclusion, this chapter has discussed about the basic chemistry of boronic acid 
and some fundamental features of boronic acid-diol binding process. Those background 
knowledge and information should have laid a good foundation of rational design and 
synthesis of boronic acid-based carbohydrate sensors.  
1.2.2 Small molecular boronic acid sensors for carbohydrates  
Due to the tremendous development in the glycobiology and glycomics areas, 
carbohydrate sensing represents an area of enormous biological importance, which 
requires a large number of tools that allow for high affinity and high specificity 
recognitions. Binders and sensors for such glycans are very useful as potential 
diagnostic tools and therapeutic agents. In the boronic acid-based carbohydrate sensing 
field, there have been hundreds of publications. Instead, the focus will be on key issues 
and approaches to consider in designing and selecting boronic acid sensors/binders for 
carbohydrates and catechols.  
The ability for the boronic/boric acid group to bind “tightly” to carbohydrates was 
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recognized over a century ago. In the 1940’s and 50’s, there were a number of excellent 
papers examining such interactions in detail.124,156-159 In the early 1990’s Czarnik138,160 
and Shinkai161 started the modern wave of interests and activities in using the boronic 
acid moiety for the design and synthesis of sensors/binders of carbohydrates. Now 
boronic acid-hydroxyl group interactions are probably the most widely used single pair 
functional group interactions in the design of sensors and “binders”.71,114,162  
In applying boronic acid-nucleophile interactions for the design of boronolectins, three 
factors need to be kept in mind: relatively low affinity, reversibility, and pH dependence. If 
these factors are not considered, one could be led to propose applications that have little 
theoretical chance of success. The pH dependence has been studied and reviewed 
extensively71,114,126,163 and will not be discussed again. The reversibility in binding is ideal 
for sensor design where “regeneration” is necessary, but may not be desirable in other 
applications. As with any binding event, the “devil is in the detail,” which is the binding 
constant. For example, the apparent binding constant between phenylboronic acid and 
glucose is only about 5 M-1 at near physiological pH.163 For fructose, mannose, galactose, 
sialic acid, mannitol, and sorbitol, the apparent binding constants are 160, 13, 15, 21, 120, 
and 370 M-1 respectively. Such numbers are far greater than what can be achieved with 
single pair functional group interactions involving, e.g., hydrogen bond, ionic interactions, 
and ion-dipole interactions in an aqueous environment. However these numbers also mean 
that at below mM concentrations of these sugar, binding is minimal. Therefore, single 
boronic acid interactions are rarely useful as “sensors” except in rare cases164 and with 
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boronic acids that have enhanced affinities.165-166 On the other hand, the “bulk” properties of 
boronic acids can be used for crude separation purposes with one caveat that one has to 
keep in mind that the intrinsic affinity differences of a boronic acid for different 
carbohydrates may bias the results if one is not careful. When the boronic acid moiety is 
used in sensor/binder design for carbohydrates, inevitably additional interactions, either a 
second boronic acid or other groups, are needed for reinforcement of the interactions. Of 
course, the three-dimensional scaffold that holds the appropriate functional groups is also 
very important.   
Another important issue in using boronic acid as the key recognition moiety for the 
design of lectin mimics (boronolectins) is the availability of boronic acids that change 
spectroscopic properties upon bindings. The incorporation of such spectroscopic reporter 
compounds allows for the generation of an intrinsic signal during binding and can greatly 
simplify detection. Along this line, many such reporter compounds have been 
reported.161,167-178 Detailed discussions are not presented here. Readers are referred to 
several extensive reviews that have covered this topic very thoroughly.71,114,179 In such an 
approach, also need to be considered are the wavelengths of the fluorophores, the 
requirement for large intensity changes for quantitation work, the requirement for the Kd to 
be comparable to the detection concentration, and covalent immobilization of the boronic 
acid in the solid-phase matrix. In this chapter, we would like to present a discussion of 
several small molecular boronic acid sensors for carbohydrate detection, most of which 
involved fluorescence change as reporting signal for binding evaluations. 
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Norrild reported a bisboronic acid-based sensor (5, Figure 1.3) capable of selectively 
binding glucose.180 In this case, two pyridylboronic acids were functionalized at both sides 
of anthracene as the bisdentate recognition moieties. The positive pyridinium groups serve 
to increase both water solubility and binding affinity of the sensor at neutral pH. NMR 
studies showed that glucose was bound at the 1,2;3,5-OH positions in its α-D-furanose 
form by the sensor (Figure 1.3). The sensor showed about 1.9- and 1.8-fold fluorescence 
intensity increases upon glucose and galactose addition (10-5~10-1 M, pH 7.4, λex: 377 nm, 
λem: 427 nm), respectively, while fructose addition resulted in no more than 10% 
fluorescence intensity changes under similar condition. The glucose-sensor binding 
constant (Ka) was calculated to be 2.5×103 M-1 using this method.  
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Figure 1.3 Complex of bisdentate boronic acid 5 with α–D-furanose glucose 1,2;3,5-OH 
groups by Norrild 
 
The Shinkai lab has successfully synthesized another boronic acid-based bisdentate 
glucose sensor (6R or 6S, Figure 1.4), with chiral discrimination ability.181 With a 
1,1’-binaphthyl moiety as the chiral and fluophore building block, saccharide-boronic acid 
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binding could affect the fluorescence intensity through photoinduced electron transfer 
(PET) involving intramolecular boron-amine interactions. The mechanism of such 
interactions has recently been extensively studied.172,182-183 Among the 
monosaccharides tested, D-glucose induced a maximum of 4-fold fluorescence intensity 
increase of 6R while only a 2-fold increase was observed with L-glucose (10-5~10-1 M, pH 
7.77, λex: 289 nm, λem: 358 nm). The situation was reversed with the 6S form, in which 
L-glucose induced twice the fluorescence intensity increase than D-glucose. Similar 
phenomenon was observed with fructose. Mass spectrum results and binding constant 
calculation supported a 1:1-complex binding pattern. Competition studies showed that 
D-glucose could be recognized by sensor 6R in the presence of L-glucose (10-3 M). Thus, 
it was concluded that selective chiral discrimination of monosaccharide enantiomers was 
achieved successfully in this case. 
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Figure 1.4 1,1’-Binaphthyl bisdentate boronic acid as chiral glucose sensor by Shinkai 
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The Lakowicz group has synthesized a series of N-(o-, m-, p-boronobenzyl)- 
6-methoxyquinolinium bromide (o-, m-, p-BMOQBA) (7, Figure 1.5) for potential tear 
glucose detection in contact lens.184-185 Due to electrostatic interactions between the 
positively charged quaternary nitrogen and the negatively charged boronate ester upon 
sugar binding, fluorescence was observed to decrease by 12-15% in the presence of 2 
mM glucose (λex: 345 nm, λem: 450 nm, pH 7.5). These glucose probes were reported to 
have good water solubility, high quantum yields (Ф: 0.5), function near physiological pH 
and show color changes in the visible region. The author suggested that tear glucose 
(0.5~5 mM in diabetic patients, ~10 fold lower than blood glucose level) sensing would 
be favored for its non-invasiveness and continuous monitoring compared with traditional 
blood glucose monitoring methods.  
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7, BMOQBA  
Figure 1.5. N-(o-, m-, p-boronobenzyl)-6-methoxyquinolinium bromide 7 by Lakowicz 
 
Among some of the computational chemistry-guided carbohydrate sensor design 
efforts, the most prominent example is the work of Drueckhammer,186 which took a 
vector-based approach for the design of boronic acid-based sensors for glucose in its 
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pyranose form (Scheme 1.4) instead of the furanose form, which is the binding form with 
many other diboronic acid compounds reported in the literature.141,180,187-192 The work 
started with the virtual “reaction” of glucopyranose with two phenylboronic acid moiety at 
the 1,2- and 4,6- positions. Then the system was subjected to quantum mechanics 
geometry optimization. The two phenylboronic acid moieties after optimization were 
considered as vectors to allow for the computational search, using the CAVEAT program, 
of rigid scaffolds that allow for the proper arrangements and orientation of these two 
boronic acid vectors for optimal complementarity. Compound 8 was an example 
candidate sensor for D-glucopyranose. As designed, 8 was able to bind D-glucose with 
high affinity and binding resulted in a decrease of fluorescence intensity. Indeed, the 
binding was in the pyranose form as demonstrated by 1H-NMR. The selectivity of the 
sensor for D-glucose versus other saccharides including D-galactose, D-mannose, and 
D-fructose was also studied. The sensor showed at least a 400-fold higher affinity for 
glucose (Kd: 2.5 × 10-5 M) than for the two other saccharides, D-galactose (Kd: 1.0 × 10-2 
M) and D-mannose (Kd : 1.6 × 10-2 M). The high selectivity for D-glucose was attributed 
to the proper scaffold of the sensor, which positioned the two boronic acid moieties 
complementary to the diol pairs of glucose. Compound 8 represents a very successful 
example of using de novo computational design for the construction of carbohydrate 
sensors. Very importantly, the same general approach should be applicable to the design 
of sensors for other saccharides and organic molecules.   
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Scheme 1.4. Vector-based approach for the design of boronic acid-based sensor 8 
for glucose in its pyranose form by Drueckhammer 
 
Different from those carbohydrate sensors with boronic acids directly attached to 
fluorphores, Singaram and coworkers developed a bimolecular sensing system 
comprising an anionic fluorphore molecule and a boronic acid modified quencher 
seperately.147,193-194 Inspired by the methyl viologen quenching fluorescence of 
8-hydroxypyrene-1,3,6-trisulfonic acid trisodium salt (HPTS, Scheme 1.5), Singaram lab 
firstly developed the system by incorporating two boronic acid moieties into viologen 
quencher to make the 4,4’-N,N’-bis(benzyl-2-boronic acid)-bipyridinium dibromide 
(4,4’-o-BBV, Scheme 1.5) quencher.193 It was proposed that the fluorescence quenching 
mechanism was mediated through electron transfer process between anionic HPTS and 
cationic viologen moiety complexed by electrostatic interactions (Scheme 1.5). Once 
carbohydrate binds to BBV, the tetrahedral anionic boronate formation will transform the 
viologen into zwitterionic neutral form, thus diminishing the HPTS-BBV electrostatic 
25 
 
 
interaction and reducing the fluorescence quenching process. It was reported that 
addition of glucose (360 mg/dL) could result in two fold fluorescence increase (λex: 461.8 
nm, λem: 511nm) of the 4,4’-o-BBV/HPTS (3×10-4 M/1×10-5 M, pH 7.4) solution (Scheme 
1.5).193 Further exploration of the BBV/HPTS was carried out through synthesizing a 
series of BBV analogues. Among them, 3,3’-o-BBV (Scheme 1.5) stands out for its 
remarkable selectivity for glucose (Ka: 1.9×103 M-1) over fructose (Ka: 1.1×103 M-1) and 
galactose (Ka: 1.8×102 M-1) in pH 7.4 phosphate buffer.147 It was suggested that the 
exceptional selectivity was achieved by binding one glucose molecule with both boronic 
acids on 3,3’-o-BBV in a chelating pattern. Besides, the low affinity of 3,3’-o-BBV 
towards lactate (Ka: 26 M-1) makes it more desirable in clinical glucose detection. 
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Scheme 1.5 Equilibrium of BBV quenching HPTS fluorescence  
 
Another multiple-component system using boronic acids for carbohydrates detection 
was the before-metioned ARS system developed by Wang group.155 In this case, ARS 
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was utilized as a separate fluorescent reporter and competitively binding toward a 
boronic acid in presence of carbohydrate analyte (Scheme 1.6). It was proposed that the 
boronic acid-ARS binding increases the ARS fluorescence intensity through removal of 
the fluorescence-quenching catechol diol protons. With a good water solubility of ARS 
(up to 10-3 M), addition of various arylboronic acids had induced about 20-80 fold of 
fluorescence intensity increase of ARS solution, accompanied with a visible color change 
from deep red to yellow at pH 7.4. Conceivably, carbohydrates competing with ARS for 
boronic acids could result in fluorescence decrease due to the disruption of ARS-boronic 
acid complex. It was reported that titrating of fructose into ARS/PBA (10-4 M/10-3 M) 
solution could induce 8-fold decrease of fluorescence intensity at 100 mM level. Using 
the three-component ARS system, the binding constant (Ka) between PBA and sialic acid 
was determined to be 21 M-1 (pH 7.4 in 0.1M phosphate buffer) by the 
Benesi–Hildebrand method.195 Thus, it was demonstrated that a general fluorescent 
assay method has been established to determine the binding constant between a 
non-fluorescent boronic acid and target carbohydrate. 
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Scheme 1.6 Competitive binding of ARS and carbohydrate toward a boronic acid 
 
Among all those carbohydrate detection by boronic acids in solution, some 
successful real-world application cases have been reported of using fluorescent boronic 
acid for cell surface glycan recognition. In the 1970s, Hageman and coworkers observed 
the interactions between boronic acid and cell surface glycans.196-198 
m-Aminobenzylboronic acid at 0.2 mM was found to inhibit sporulation of Bacillis subtilis 
without affecting its vegetative growth.197 Since the culturing cells were highly clumped at 
later stage in the presence of a boronic acid and the sporulation inhibition could not be 
reversed by diluting the inhibitor, it was proposed that m-Aminobenzylboronic acid might 
bind to the cell surface carbohydrate through boronate ester formation. Later on, with 
fluorescent boronic acid 9 (Figure 1.6), Bacillis subtilis was visibly fluorescent labeled 
and the labeling could be reversed by mannitol solution.196 In addition, it was found that 
another synthesized double-headed boronic acid 10 (Figure 1.6) was capable of 
agglutinating both type O human erythrocytes and sheep erythrocytes in similar 
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pattern.196 It was proposed that the double-headed reagent agglutinate cells through 
cross-linking, acting in a similar way as lectins. All such results suggested that boronic 
acids can be used to bind cell-surface glycans. 
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Figure 1.6 Cell surface binding boronic acids by Hageman 
 
 Promising cell-surface glycan binding results were reported of a bisboronic 
acid-based fluorescent sensor for selectively labeling sLex-expressing cells (Figure 1.7)  
by Wang and coworkers.142,199 The design strategy was based on the idea that with a 
proper linker, two boronic acid moieties could be appropriately arranged to complement 
the diol/hydroxyl structures on sLex. Shinkai’s anthracene-based boronic acid system 
was chosen as the fluorophore in this case, for it showed significant fluorescence 
intensity increases upon sugar binding.161,200 Among all the linkers chosen, 
para-disubstituted phenyl ring 11a (Figure 1.7) showed the best binding and selectivity 
for sLex. Fluorescent cell labeling studies showed that 11a selectively labeled sLex 
expressing HEPG2 cells while non-expressing COS7 cells and Lewis Y (Ley, Figure 1.7) 
expressing HEP3B cells were not labeled. HEPG2 cells treated with neuraminidase and 
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fucosidase resulted in significantly decreased labeling, indicating that both the fucose 
and sialic acid residues were required for 11a labeling of HEPG2 cells. A control 
bisboronic acid (11b) showed no similar labeling. Small molecule lectin mimics such as 
11a can be very useful for cell-specific delivery of imaging and therapeutic agents. 
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Figure 1.7 Bisboronic acids 11a and 11b by Wang for sialic Lewis acids binding 
1.2.3 Conclusion  
In conclusion, based on the fundamental chemistry knowledge of boronic acids, all the 
successful cases of carbohydrate detection using small moleculr boronic acids show a 
promising scenario of further exploring its application. Nevertheless, one of the most 
important contemporary challenges in using boronic acids for the design of carbohydrate 
sensors is in the selection of the appropriate scaffold to position the boronic acid and 
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other functional groups in appropriate places and orientations in order to afford the 
necessary specificity and affinity. Single boronic acid-diol interaction by itself is too weak 
to lead to high affinity and selectivity. The situation was improved somehow with 
bisboronic acid sensors with proper positioning of the bisdentate moieties. However, 
finding a good sensor is a very chance-dependent case and so far only a limited number 
of such applications have been reported. Meanwhile, complementing to the rational de 
novo design approach of small molecular boronic acid sensors design, template-directed 
synthesis and combinatorial library approaches could overcome the problem to some 
extent, since no detailed structural information of the analytes are required in buiding 
those polymer-based boronic acid sensors. 
1.3   Boronic acid sensors based on non-biopolymers 
1.3.1 Brief introduction of polymer-based boronic acid sensors 
In general, there are two classes of polymer-based boronic acid sensors, 
non-biopolymers and biopolymers. Biopolymers like polypeptides and oligonucleotides 
serving as scaffold for boronic acid positioning are often created through a combinatorial 
approach to yield a large molecular library with high diversity, which is later screened 
against carbohydrate analytes to select proper “binders”. In contrast, 
non-biopolymer-based boronic acid sensors are usually generated through two other 
strategies. The first one involves self-assembled monolayer (SAM) functionalized with 
boronic acid moieties as glycan trap. This method is often coupled with highly-sensitive 
detection techniques such as quartz crystal microbalance (QCM)201 or surface plasma 
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resonance (SPR).202 The second approach to construct carbohydrate sensors/binders is 
template-directed synthesis such as molecular imprinting technique, which has the 
desired feature of not requiring prior knowledge of the carbohydrate 3-dimensional 
structures. Details of each approach are discussed in the following sections. 
1.3.2 Self-assembled monolayer (SAM)-based boronic acid sensors 
Boronic acid-based SAM was constructed by the Fernandez group as an affinity-trap 
for glycoprotein horseradish peroxidase (HRP) detection.201 Gold film surface was first 
coated with 6,8-dithioctic acid, which was then linked to 3-aminophenyl boronic acid 
(Figure 1.8).  Presumably, in binding the carbohydrate moieties of HRP were brought 
into the proximity of the boronic acid groups through multiple weak interactions. In QCM 
tests, addition of glycosylated HRP caused a ~17 Hz frequency decrease while 
deglycosylated HRP only caused a less than 2.5 Hz decrease. The 7-fold difference 
indicated that the adsorption on boronic acid-based SAM trap was mediated and 
differentiated based on the saccharide portion.  
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Figure 1.8 Boronic acid-based SAM glycoprotein trap by Fernandez 
 
SPR was used by the Chen group for glycoprotein detection using boronic acid 
SAM.202 Glycated hemoglobin HbA1c, formed by non-enzymatic glycation of the 
hemoglobin β chain with glucose on the N-terminal valine, was chosen as the target 
because its level can be used as a clinical indicator for chronically elevated sugar level in 
diabetic patients. Gold surface was coated with dithiobis(4-butylamino-m-phenylboronic 
acid) (DTBA-PBA) SAM. The SPR results showed that the detection limit of HbA1c was 
0.01μg/ml and good linear regression was obtained in the concentration range from 0.43 
to 3.49 μg/ml (pH 9). Compared with traditional tests,203-204 this method showed 
approximately a 1000-fold increase in sensitivity. The SPR sensitivity could be improved 
another 5-fold by adding a Lewis base when HbA1c concentration was lower than 50 nM. 
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Thus, both high sensitivity and specificity of HbA1c sensing were achieved using this 
DTBA-PBA-SAM-SPR method. 
1.3.3 Molecular imprinted polymer boronic acid sensors 
Among the different template-directed synthesis approaches, molecular imprinting is 
especially useful in creating receptor sites for organic molecules including carbohydrates. 
Molecular imprinting is a technique first demonstrated in the late 40's by Dickey.205 It 
involves 3 steps including: 1) mixing the template/analyte with the functional monomers 
and cross linkers at low temperature to allow for complementary intermolecular 
interactions; 2) polymerization of the monomers and cross linkers under mild conditions; 
and 3) extraction of the template molecules from the polymers, which leaves behind 
polymeric sites with memories of the template molecules in terms of size, shape, and 
functional group orientations (Scheme 1.7). This technique has been used for the 
preparation of selective recognition sites for a wide variety of molecules.206-208 Naturally, 
the same method has been used for the preparation of sensors,209 including boronic 
acid-based carbohydrate sensors.  
mixing template, functional 
monomers and cross linkers
polymerization of functional
monomers and cross linkers
extraction of template
molecules
Scheme 1.7 Molecular imprinting process 
 
 
34 
 
 
Wulff first demonstrated the use of boronic acid compounds in molecular imprinting 
for the construction of polymeric cavities specific for certain saccharides.210 D-fructose 
and D-galactose were used as the template compounds. Specifically, these sugars were 
first conjugated with 2 equivalent of VPB ((4-vinylphenyl)boronic acid), presumably at 
2,3;4,5-OH of fructose and 1,2;3,4-OH of galactose, to yield their respective 
polymerizable monomers. EGDMA (ethylene glycol dimethacrylate) was used as the 
cross linker. The polymers prepared were shown to have “memories” of the template 
including stereochemical features. For example, the D-fructose-imprinted polymer could 
differentiate the D-form from the L-form by a factor of 1.47-1.63. It is interesting to note 
that the D-fructose- imprinted polymer could also differentiate L-galactose from 
D-galactose by a factor of 1.17 while D-galactose-imprinted polymer could differentiate 
L-fructose from D-frucose by a factor of 1.25. It was proposed that the high similarity 
between D-fructose and L-galactose as well as L-fructose and D-galactose in terms of 
their spatial hydroxyl group arrangements was responsible for the observed cross 
reactivities.  
Using the same imprinting principle, the Wang lab was the first to synthesize boronic 
acid-based fluorescent polymers for saccharides as potential fluorescent sensors.211-212 
In such studies, a polymerizable boronic acid monomer (12) was prepared (Figure 1.9). 
The anthracene-based boronic acid unit in 12 is known to increase fluorescent intensity 
upon sugar binding as reported by the Shinkai lab.139,213 The monomer was first reacted 
with D-fructose to form a covalent complex before polymerization in the presence of 
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EGDMA as the cross linker. In re-binding studies, the fructose-imprinted polymer showed 
significant fluorescent intensity changes (over 100%) upon fructose addition. This 
polymer also showed preference for D-fructose over D-glucose and D-mannose, which 
was at least twice as large as that determined with the control boronic acid alone.   
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Figure 1.9  Boronic acid monomer 12, 13a, cross-linker 13b and 
4-nitrophenyl-α- D-mannopyranoside 
 
In yet another example, Kurihara and coworkers214 conducted surface imprinting of 
4-nitrophenyl-α-D-mannopyranoside with a polymerizable phenylboronic acid monomer, 
(3-(10’,12’-penta-cosadiynamido)phenylboronic acid) 13a and cross-linker 13b (Figure 
1.9). 4-Nitrophenyl-α-D-mannopyranoside (Figure 1.9) was used as the template 
molecule and the 4-nitrophenoxy group can be used to quantify the binding by UV-visible 
spectroscopy. In re-binding studies using both imprinted and control polymers, about 
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75% the binding sites of the imprinted surface were occupied by the template, while 
about 57% of the non-imprinted surface was covered. This implied that the imprinted 
monolayers had an improved affinity for the template molecule.    
Molecular imprinting technique is also used in developing boronic acid-based 
electrochemical sensors. Usually, thick imprinted polymer layer on the electrode surface 
is unfavorable since it hinders analytes diffusion and retards polymer-electrode 
communication. The problem can be partially overcome by utilizing thin layer polymer 
film electropolymerization on electrodes or on the gate surface of an) device through 
radical polymerization.215-217 In such cases, the barrier of analyte diffusion and electrical 
contact is minimized. In this regard, the Willner group reported the copolymerization of 
acrylamide-acrylamide- phenylboronic acid on TiO2 film for imprinting AMP, GMP and 
CMP.217 Charging the boronic acid polymer membrane with nucleotides controlled the 
gate potential of the ISFET to allow for detection of each nucleotide. Similar thin layer 
boronic acid polymers were constructed by the same group towards various nucleotides 
and monosaccharides on Au electrodes, piezoelectric Au quartz crystals, or on the gate 
surface of ISFET device.215 Faradaic impedance spectroscopy measurement showed 
enhanced selectivity for the template molecules by increasing the cross-linking degree of 
the polymer. Most recently, the same group reported fabrication of stereoselective and 
enantioselective imprinted polymer for monosaccharides such as D-glucose and 
D-mannose.216 The co-electropolymerization of phenol with a 3-hydroxyphenyl boronic 
acid-monosaccharide complex on Au support created a thin film of boronate-conjugated 
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polyphenol layer coated electrode (14, Figure 1.10). Competitive electrochemical assay 
was carried out by measuring the amperometric responses using ferrocene 
modified-monosaccharides (15, Figure 1.10) as the redox labels to analyze each 
saccharide’s binding affinity. The observed stereoselectivity and enantioselectivity 
indicated that rather delicate structural contour was constructed around saccharide 
template with boronic acid and other motifs accommodating the hydroxyl groups in a 
delicate coordination way.  
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Figure 1.10 Boronic acid-contained polyphenols 14 and ferrocene-monosaccharide 
redox labels 15 
 
Flow calorimeter was used by the Scheller group218 to study the interactions of 
phenylboronic acid-based polymers imprinted with fructosyl valine (Fru-Val), fructose 
and pinacol, respectively. Fru-Val is known as the N-terminal glycated amino acid on 
glycosylated hemoglobin (HbA1c) (HbA0 is the non-glycated hemoglobin). The imprinted 
polymer for Fru-Val was prepared by copolymerizing the complex of Fru-Val and VPB 
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with cross linker TRIM (trimethylolpropane trimethacrylate). An exothermic peak signal 
was observed when Fru-Val flew through the imprinted polymer in a thermistor. This was 
followed by an almost steady state signal.  The intensity of the peak signal increased in 
response to Fru-Val in a concentration- dependent manner (up to 5 mM). Control 
polymer prepared from the pinacol-VPB complex in the same way didn’t give such 
significant signal changes. The apparent imprinting factor (IF), the ratio of binding with 
imprinted polymer to that with the control polymer at equilibrium, was determined as 41 
by measuring the signal intensity ratios. The temperature increase induced by Fru-Val 
interactions with imprinted polymer was 2.4-fold higher than that of fructose-imprinted 
polymer interactions and 270-fold higher than that of Val-imprinted polymer interactions. 
Thus, a selective Fru-Val MIP sensor was developed and used in calorimeter 
measurements. 
1.3.4 Conclusion  
In conclusion, boronic acids have very unique properties and can be used as a key 
functional group in the construction of polymer-based sensors/binders for carbohydrates 
or glycans. Non-biopolymer sensors functionalized with boronic acids have been 
reported through either self-assebling monolayer (SAM) technique or template directed 
synthesis. Neither of these strategies requires prior knowledge of the analytes’ detailed 
structural information. Which SAM-based boronic acid sensors primarily rely on sensitive 
detection methods such as SPR or QCM, more detection methods are available for 
evaluation of molecular imprinted boronic acid polymer sensors such as spectroscopic, 
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electrochemical and flow calorimetric methods. 
1.4   Boronic acid sensors based on biopolymers 
1.4.1 Brief introduction of biopolymer-based boronic acid sensors 
Though the discussion of template-directed boronic acid-based sensor work has 
been focused on non-biopolymers, one should not feel restricted by this. Such an 
approach is in line with dynamic combinatorial library work, which has been proven 
useful.219-223 For example, one could envision the linking of two boronic acids through a 
tether in a library consisting of multiple boronic acids and linker species. Such a library 
could give a large number of bisboronic acid end products. Using combinatorial 
chemistry to create a library and then screening the library against the target analytes to 
select binders, the library synthesized can be either small molecular ligands,117,224-225 
peptide-based boronic acid library (PBLs),226-230 or nucleic acid-based boronic acid 
library (NBLs).231-232 Similar with the non-biopolymer version, the biopolymer-based 
boronic acid sensors design doesn’t need prior knowledge of the structural and 
conformational information of the carbohydrates either. Besides, the chemical synthetic 
approaches of biopolymers such as peptides and nucleic acids are very mature and 
well-established techniques, which provide more convenience and promise in their 
libraries construction. Furthermore, the biological nature of peptides and nucleic acids 
also has the implication that such types of boronic acid sensors could possibly be 
generated through enzymatic approaches in vitro231 or through cellular machinery in 
vivo.233 
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1.4.2 Peptide based boronolectin 
Recently, there have been some efforts in developing libraries of peptide-based 
boronolectins (PBLs), which offer the chance of searching for binders through 
combinatorial/diversity-based approaches. Along this line, the labs of Anslyn,226 Hall,228 
Duggan,229-230 and Lavigne227 have independently made significant contributions.   
In the work from the Anslyn group, arrays of boronic acid derived pentapeptide 
receptors (16, Figure 1.11) were constructed for saccharide sensing.226 The 
pentapeptide receptors were selected from a random pool of a synthesized library. The 
binding affinity of each resin-bound receptor (RBR) was evaluated colorimetrically using 
an indicator displacement method first developed in the Anslyn lab. In this case, 
bromopyrogallol red (BPR) was chosen as the indicator and Linear Discriminant Analysis 
(LDA) was used to process BPR-uptaking data to identify receptor-analyte binding 
patterns. Collectively, the unique pattern of each PBL receptor in the chemosensor array 
successfully differentiated monosaccharides from disaccharides, and discriminated 
isomers within each group. Sucrose and maltose were also differentiated from their 
low-calorie counterpart (sucralose and maltitol). Furthermore, sucralose was identified 
successfully in Splenda sweetened tea using the same chemosensor array chip with the 
LDA data set. It was reported as one of the first assays that supramolecular 
pattern-based sensors identified a sweetener in a real world beverage sample.  
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Hall and coworkers have developed a triamine-derived triboronic acid library228 using 
the combinatorial split-and-pool strategy.234-236 The triamine backbone was synthesized 
with tripeptides as the starting point, followed by exhaustive reduction of the amide group 
to amine and functionalization of the amine with phenylboronic acid (17a, Figure 1.12). 
Lewis-b (Leb) tetrasaccharide, which is a type of cell surface oligosaccharide commonly 
expressed on bacteria, red blood cells or tumor cells, was chosen as the binding 
target.107,237 Though the study did not yield strong binders, this was an example of 
proof-of-concept that a library of receptors containing more than two boronic acid units 
was constructed in a controlled manner and individual library members were 
successfully characterized by HPLC and ESI-MS after cleavage. Thus, it has the 
potential for future optimization and application in screening against saccharides for high 
affinity and selectivity recognition. In addition to this example, a resin-to-resin transfer 
reaction (RRTR) (of arylboronic acid) was developed by the Hall group and could also be 
used in PBL library construction in the future.238 
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Figure 1.12 PBL library 17a and encoding moiety 17b by Hall  
 
Duggan and co-workers also prepared solid-supported PBL libraries derived from 
4-borono-L-phenylalanine (BPA, 18, Figure 1.13).229-230 The pentapeptide-based 
bisboronic acids including a ‘lysine series’ and an ‘arginine series’ (Table 1.1) were 
tested for their affinity toward various monosaccharides using competitive binding assay 
against Alizarin Red S (50% methanol/50 mM NaHCO3, pH 10.7), first developed by the 
Wang lab.163,239 It was hypothesized that the positively charged Lys and Arg residues 
could enhance boronic acid-diol binding by ion-pairing with negative-charged boronate 
esters. Test results showed that optimal binding towards fructose and glucose was 
achieved when two BPA units were adjacent or separated by one amino acid residue; 
e.g., the tightest D-glucose binding sequence was Arg PBL 1 (Ka: 3641 M-1) and the 
tightest D-fructose binding sequence was Lys PBL 12 (Ka: 4162 M-1). While Arg PBL 4 
and 6 showed an 8.3- and 5.4-fold preference for D-fructose binding, Lys PBL 8 showed 
a 2.1- fold preference for D-glucose binding. More interestingly, in chiral discrimination 
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binding studies, Arg PBL 4 displayed an 8.4-fold preference for L-glucose while Lys PBL 
12 showed a 4.3-fold preference for D-glucose. Thus, it was clearly demonstrated that 
affinity and selectivity of PBL binding towards saccharide could be greatly influenced and 
finely tuned through peptide backbone modifications. The requirement of the PBA 
residues to be close to each other to achieve high specificity might also suggested that 
binding was a well coordinated and cooperated process.  
B
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18, p-boronophenylalanine 
Figure 1.13 Structure of p-boronophenylalanine 18 
Table 1.1 Amino acid sequences of Arg series (1-6) and Lys series (7-12) PBLs by 
Duggan 
1 N-Ac-BPA-BPA-Ala-Arg-Arg-AHA-SS
2 N-Ac-BPA-Arg-BPA-Ala-Arg-AHA-SS
3 N-Ac-BPA-Arg-Arg-BPA-Ala-AHA-SS
4 N-Ac-BPA-Arg-Ala-Arg-BPA-AHA-SS
5 N-Ac-Arg-BPA-BPA-Arg-Ala-AHA-SS
6 N-Ac-Arg-BPA-Arg-BPA-Ala-AHA-SS
7 N-Ac-BPA-BPA-Ala-Lys-Lys-AHA-SS
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8 N-Ac-BPA-Lys-BPA-Ala-Lys-AHA-SS
9 N-Ac-BPA-Lys-Lys-BPA-Ala-AHA-SS
10 N-Ac-BPA-Lys-Ala-Lys-BPA-AHA-SS
11 N-Ac-Lys-BPA-BPA-Lys-Ala-AHA-SS
12 N-Ac-Lys-BPA-Lys-BPA-Ala-AHA-SS
*AHA=6-aminohexanoic acid, SS= solid support. 
 
Lavigne and coworkers have synthesized a PBL library on aminomethyl PEG-PS 
resin and demonstrated its applications in cancer related glycoprotein detection.227 A 
12-mer PBL library with a sequence of Cbz-A-(X)10-A-resin (A: alanine, X: 
2,3-diaminopropanoic acid, 2,4-diaminobutanoic acid, ornithine, lysine, or alanine) was 
synthesized using the split-and-pool method,235-236,240-241 and 2-formylphenylboronic acid 
was coupled to the side chain amine through reductive amination. Fluorescein 
isothiocyanate (FITC)-labeled glycoproteins, including ovalbumin (Oval), bovine 
submaxillary mucin (BSM), and porcine stomach mucin (PSM), were incubated with the 
resin-bound PBL library in the presence of 1% BSA (bovine serum albumin) and 10% 
glycerol. Using microscopic image screening, beads selective for Oval and BSM, 
partially cross-reactive for both BSM and PSM, and completely cross-reactive with all 
glycoproteins were observed. In contrast, non-PBL resin did not bind any glycoprotein 
and non-glycosylated protein BSA did not significantly bind any beads. Such control 
45 
 
 
results indicated that the binding process was PBL- and saccharide-dependent. 
Inclusion of PBL resin beads in microtiter plate arrays generated specific color patterns 
for binding Oval, BSM and PSM. Thus, although no individual PBL bead was isolated 
and characterized, the general results described illustrated the potential of this PBL-resin 
array in future diagnostic applications in selective glycoprotein detection.  
Different from the above PBLs synthesized through combinatorial chemistry, Schultz 
and coworkers developed a method for producing boronate containing protein through 
site-specific incorporation of genetically encoded BPA (18, Figure 1.13) in E. coli.233 An 
orthogonal tRNA/aminoacyl-tRNA synthetase (aaRS) pair encoding BPA was generated 
through altering the specificity of Methanococcus jannaschii (Mj) derived amber 
suppressor tyrosyl tRNA (MjtRNATyrCUA)/tyrosyl- tRNA synthetase (MjTyrRS) pair. 
Expression experiment results showed that protein was only produced in the presence of 
BPA by E. coli with plasmid containing MjtRNATyrCUA and evolved BPA-tRNA synthetase. 
The expressed boronate-containing protein was characterized by ESI-MS. The protein 
was able to bind polyhydroxyl compounds such as glucamine and sorbitol through 
boronate ester formation. In fact, it was also proposed that intramolecular 
serine-boronate crosslink was formed in the protein based on the crystal structure of 
previously reported original protein and the ESI-MS of the boronate protein. In fact, 
boronate ester formation of the protein with polyhydroxylated compound was so 
significant that one-step scarless affinity purification of the boronate protein was 
achieved with N-methylglucamine conjugated resin. Thus, it was proposed that this 
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technology could be applied in the development of boronate containing antibody for 
glycoprotein detection or in vivo labeling of boronate protein with polyhydroxylated 
reporters. 
1.4.3 Nucleic acid based boronolectin 
In the area of nucleic acid-based lectin mimics, there have been extensive activities. 
For example, the Yu group developed unmodified RNA aptamers for oligosaccharide 
(sLex) detection;242 the Anslyn group developed unmodified RNA to fine-tune the 
selectivity of an existing small molecule carbohydrate receptor.232 The aptamers 
selection process followed essentially those SELEX (systematic evolution of ligands with 
exponential enrichment) techniques first developed by the labs of Szostak, Joyce, and 
Gold.243-245 Recently, the Wang lab has successfully developed a boronic acid-modified 
TTP analogue (B-TTP) that can be enzymatically incorporated into DNA sequence, and 
discussed its potential application for aptamer selection in glycoprotein detection and 
differentiation.71,231  
The Anslyn lab232 used unmodified RNA aptamers to tune the selectivity of a boronic 
acid-based receptor with great success. For example, bis-boronic acid 19 (Figure 1.14) 
by itself was known to bind citrate (Kd: 5.5 ×10-6 M-1) slightly better than tartate (Kd: 7.1 
×10-6 M-1). The immobilized bis-boronic acid receptor 20 on glyoxal agarose beads 
(Figure 1.14) was subjected to an RNA pool (N50) SELEX in the presence of 200 µM 
tartate. Negative selection was performed on the RNA pool against the immobilized 
tris-amine beads 21 as blank control (Figure 1.14) before each round of SELEX to 
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increase the selection specificity. The RNA binding to the complex of receptor-tartate 
became dominant in the pool from the 7th round. In radio-labeled binding assays, all 
seven families of the cloned RNA aptamers showed their preference of binding the 
receptor-tartate complex (from 12 to 25%) to the receptor alone (<7%). One specific 
sequence was used in the fluorescence binding test of receptor towards analytes. In the 
presence of this aptamer, the receptor was able to bind tartate with Kd of 2.1 ×10-4 M-1 
while no binding to citrate was observed (Kd >3 ×10-3 M-1). Thus, the selectivity of the 
bis-boronic acid was tuned to at least 14-fold higher for binding tartate than citrate in 
presence of the selected aptamer. In comparison, the receptor had a 1.3-fold higher for 
citrate than tartate in the absence of aptamer.  
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Based on the general aptamer selection method developed about 18 years ago by 
the labs of Szostak, Joyce, and Gold,243-245 the Wang lab are on the effort of developing 
a methodology of using boronic acid modified DNA to select aptamers that can recognize 
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an intact glycoprotein with the ability to differentiate glycosylation variations. This was 
achieved through the incorporation of a boronic acid modified thymidine moiety (B-TTP, 
Figure 1.15) into the DNA sequences.246 Because of the intrinsic affinity of boronic acids 
for carbohydrates, the hypothesis was that the incorporation of the boronic acid moiety 
would allow for the aptamer selection process to gravitate toward the “sweet spot” 
(glycosylation site) and therefore allow for distinction of glycosylation variations. In 
another word, this method of using boronic acid-modified DNA allows for the selection to 
go after the “sweet spot.” The boronic acid moiety was functionalized with a terminal 
azido group and attached to the linear linker at 5-position of thymidine triphosphate via 
Cu(I)-catalyzed azido-alkyne cyclization (CuAAC) reaction.247-249 It was demonstrated 
that B-TTP can be successfully recognized by DNA polymerase as substrate and 
incorporated into elongating DNA sequence. Both MALDI-MS and gel electrophoresis 
results support completion of full length DNA polymerization using B-TTP in place of 
natural TTP in reaction. Further experiment showed that DNA polymerization and 
amplification using boronic acid-labeled DNA as template was achieved with no 
noticeable difference from using natural DNA template. Thus, it is not surprising that 
PCR amplification of DNA using B-TTP was also attained. Among all those observed 
results, it should be specifically noticed that in one particular experiment, the boronic 
acid-modified DNA gel-shift band was separated from natural DNA band with the same 
length and composition in the catechol-modified PAGE result. Since it is commonly 
known that catechol is capable of forming tight complex with boronic acid,125-126,250-251 the 
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gel-shift result serves as a good indication that the diol-binding ability of boronic acid was 
well retained after being tethered to DNA backbone. Thus, all those preliminary results 
are good proof-of-concept evidence supporting the feasibility of proposed idea of 
developing boronic acid-based aptamers, or nucleic acid-based boronlectins (NBLs) in 
the future. 
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Figure 1.15 Boronic acid modified TTP (B-TTP) by Wang 
  
1.4.4 Conclusion  
In general, the biopolymer-based boronic acid sensors are created in a combinatorial 
approach for either PBLs or NBLs. There have been several array methods for 
evaluating PBL libraries using colorimetric detection methods, which is similar to the 
lectin-microarray analysis of glycans.226-227 However, very limited number of the 
individual PBL affinity toward carbohydrate analytes was reported. For the one by 
Duggan, the highest PBL affinity toward carbohydrate was estimated to be around Ka of 
4000 M-1, which means most of the PBLs were at Kd of about -mM level binding 
affinity.230 It is understandable since none of those constructed PBLs were designed 
purposely to have the structural conformation complementary to the target carbohydrate 
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analytes. Thus, colorimetric array methods may be a better method to evaluate PBLs 
because it’s the binding- pattern profiles that serve as the comparing parameters. In 
contrast, NBLs for carbohydrate recognition are still under a developing stage. As 
reported, the SELEX technique often generates aptamers of binding affinities that rival 
antibodies. In one particular case, Yu and coworkers have selected out RNA aptamers 
against sLex with Kd values around 10-9 to 10-11 M.242 Yet, the selected aptamers also 
showed cross-reactivity issue among Lewis acid group, a similar problem resembling 
lectins. This could be explained as a result from the nature of their interactions, which 
were still based on hydrogen bond and hydrophobic interactions. Anslyn and coworkers 
did an excellent work by combining the power of SELEX and boronic acid-carbohydrate 
interaction together to address that issue.232 But in his experiment, the aptamers and 
boronic acids were still separated molecules working together, and the aptamers were 
only playing a tuning role in the entire binding process. In that sense, Wang lab is 
working on recruiting the boronic acid moieties into the nucleic acid molecules for further 
SELEX procedure.231 It was proposed that the intrinsic affinity of boronic acids toward 
carbohydrates would probably lead the selecting process to bias on such interactions to 
generate more selective aptamers. Thus, efforts of constructing boronic acid-modified 
nucleic acid aptamers are carried out on this way. 
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1.5 The objectives and contributions of this dissertation 
The objective of this research is to synthesize a new fluorescent B-TTP building block 
that can be enzymatically incorporated into DNA. Ideally, the boronic acid should show 
fluorescent intensity increase at a visible wavelength upon glycan binding as the 
reporting signal. It is critical that the property of fluorescence change for the new B-TTP 
be maintained even after DNA incorporation. In this case, naphthalimide-based boronic 
acid (NB) developed by our lab was chosen as the moiety to be linked to TTP, because 
of its long excitation/emission wavelengths and fluorescence increasing properties. 
Preliminary studies of several designed and synthesized NB-DNA were carried out to 
evaluate the fluorescence changes upon model sugar binding. It was proposed that by 
optimizing the DNA sequence and structure, the DNA-based boronic acid sensors with 
high affinity and selectivity against specific glycan target could be obtained. The work 
described in this dissertation consists of the following three key parts: 
A. Synthesizing new B-TTP with intrinsic long-wavelength fluorescence 
Along the line of trying to develop nucleic acid-based boronolectins, a new B-TTP 
was synthesized using similar strategy as previous one.231 The advantage or 
improvement of the new B-TTP is that the chosen naphthalimide-based boronic acid (NB) 
fluoresces at long-wavelength and its fluorescence intensity increases upon 
carbohydrate binding. It was discovered that the fluorescent properties of NB were well 
retained after tethering to the 5-position of TTP, and the new B-TTP could be recognized 
by DNA polymerase as a substrate. 
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B. Fluorescence properties studies of NB- modified DNA sequences 
After incorporation of NB-TTP into DNA sequences, fructose as model carbohydrate 
was added into the DNA solution to study its fluorescence change. It was observed that 
the fluorescence intensity increased in a concentration-dependent manner. Further 
experiments involved several bis-boronic acid DNA sequences with different number of 
bases as a spacer in between. In addition to fructose, three disaccharides were also 
tested for their effects on changing NB -DNA fluorescence. 
C. In vivo cell imaging study of NB-TTP 
Encouraged by the in vitro enzymatic activity of NB-TTP, we were interested in seeing 
the NB-TTP in vivo activities in cell cultures, which can be observed under fluorescent 
microscope. In this work, it was surprising to see that NB-TTP not only was capable of 
getting through cell membrane into cytoplasma, but also showed significant 
accumulation in the cell nucleus. The result could be very useful for developing 
fluorescent cell nucleus-labeling agents, or even mapping glycan distribution in living 
cells. 
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2. MATERIALS AND METHODS 
. 
2.1 Synthesis of napthalimide-based boronic acid modified TTP (NB-TTP) 
Unless otherwise noted, starting materials and solvents were purchased from Aldrich 
and Acros, and used without purification. 1H and 13C NMR spectra were recorded on a 
Bruker 400 MHz spectrophotometer in a deuterated solvent with TMS (δ = 0.00 ppm) or 
NMR solvent as the internal reference unless otherwise specified. 31P NMR was 
recorded using 85% H3PO4 as an external reference (in an insert). HPLC purification 
was carried out with a Zobax C18 reversed-phase column (9.4 mm×25 cm). 
Fluorescence spectra were recorded on a Shimadzu RF-5301 PC spectrofluorometer. 
Absorption spectra were recorded on a Shimadzu UV-1700 UV/Vis spectrophotometer. 
Quartz cuvettes were used in all fluorescence and UV studies. All pH values were 
determined by a UB-10 Ultra basic benchtopp H meter (Denver Instruments). For all 
reactions, analytical grade solvents were used. Anhydrous solvents were used for all 
moisture-sensitive reactions.  
4-Aminomethylbenzyl alcohol (2): 
4-(Hydroxymethyl)benzonitrile (1.0 g, 7.5 mmol) dissolved in dry THF (20 ml) was 
added slowly into a suspension of LiAlH4 (866 mg, 22.8 mmol) in THF(20 ml) at RT. 
Foaming with bubble formation was observed while stirring. The light yellow-green 
suspension was refluxed under N2 overnight. After cooling down to RT, MeOH (5 ml) was 
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added to the suspension to quench the reaction. The suspension generated foams while 
being stirred and cooled in an ice-bath. When no more bubble formation was observed, 
NaOH (20%, 15 ml) solution was added into the suspension. The solution became 
colorless while white precipitate was observed. The solution was concentrated in vaccuo 
and the residue was suction-filtered. The solid was repeatedly washed with CH2Cl2. The 
filtrate was combined and washed with H2O. The organic phase was separated and 
concentrated on a rotavap. White solid was obtained as product (1.0 g, 98% yield). The 
product underwent prolonged drying in vaccuo to remove residue solvent before the next 
step reaction. 
1H-NMR (CDCl3): δ7.31 (m, 4H), 4.67(s, 2H), 3.85 (s, 2H), 1.76 (s broad, 3H) 
13C-NMR (CDCl3): δ142.7, 139.9, 127.5, 127.5, 65.2, 46.4 
4-Boc-aminomethylbenzyl alcohol (3): 
Into the solution of 4-aminomethylbenzyl alcohol (444 mg, 3.2 mmol) and 
triethylamine (0.47 ml, 3.3 mmol) in dry THF (5 ml) was added di-t-butyl dicarbonate (750 
mg, 3.4 mmol) in dry THF (3 ml) dropwise. The mixture was stirred at RT overnight and 
then concentrated on a rotavap. The residue was dissolved in ethyl acetate (20 ml). The 
solution was sequentially washed with NaHSO4 solution (5%, × 1), saturated NaHCO3 
solution (× 1) and brine (× 1), and then dried over MgSO4. Filtration and solvent 
evaporation yielded a white powder product (720 mg, 94% yield). 
1H-NMR (CDCl3): δ7.27 (m, 4H), 4.92 (s broad, 1H), 4.65 (s, 2H), 4.27 (d, 2H), 2.22 (s 
broad, 1H), 1.45 (s, 9H) 
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13C-NMR (CDCl3): δ156.1, 140.3, 138.4, 127.8, 127.4, 79.7, 65.1, 44.6, 28.6 
(4-Boc-aminomethylbenzyl) methansulfonate (4): 
Into the solution of 4-Boc-aminomethylbenzyl alcohol (700 mg, 3.0 mmol) and 
triethylamine (0.86 ml, 6.2 mmol) in dry THF (12 ml) in an ice bath, MsCl (0.38 ml, 4.9 
mmol) was added dropwise. The mixture was stirred for 1 h in an ice bath. The solution 
was concentrated on a rotavap and the residue was dissolved in 25 ml of ethyl acetate. 
The solution was sequentially washed with NaHSO4 solution (5%, × 1), saturated 
NaHCO3 solution (× 1) and brine (× 1), and then dried over MgSO4. After filtration and 
solvent evaporation, a colorless oil product was obtained (896 mg, 96% yield), which 
turned into white solid after prolonged drying in vacuo. 
1H-NMR (CDCl3): δ7.35 (m, 4H), 5.22 (s, 2H), 4.95 (s broad, 1H), 4.33 (d, 2H), 2.91 (s, 
3H), 1.46 (s, 9H) 
13C-NMR (CDCl3): δ156.1, 140.7, 132.5, 129.4 128.0, 79.9 71.4, 44.4, 38.5, 28.6 
4-Amino-N-(4’-boc-aminomethylbenzyl)naphthalimide (5): 
4-Amino-naphthalimide (820 mg, 3.85 mmol) in dry DMF (20 ml) was treated with 2 M 
NaOMe in MeOH (3 ml) until it became a homogenous solution with a deep red color 
(took several minutes). (4-Boc-aminomethylbenzyl) methansulfonate (1.21 g, 3.85 mmol) 
was then added. The solution was stirred for 3 h and then quenched by adding H2O (100 
ml). The suspension was extracted with ethyl acetate (100 ml, × 2). The organic 
extractions were combined and concentrated into 100 ml. The solution was washed with 
H2O (25 ml, × 3) and dried over MgSO4. The removal of solvent on a rotavap gave an 
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orange powder product (1.5 g, 90% yield). 
1H-NMR (D6-DMSO): δ8.63 (d, 1H, J = 7.6 Hz), 8.44 (dd, 1H, J1 = 7.2 Hz, J2 = 0.8 Hz), 
8.21 (d, 1H, J = 9.2 Hz), 7.66 (t, 1H, J = 8.0 Hz,), 7.49 (s broad, 2H), 7.20 (m, 4H), 6.86 
(d, 1H, J = 8.4 Hz), 5.19 (s, 2H), 4.06 (d, 2H, J = 6 Hz), 1.366 (s, 9H) 
13C-NMR (D6-DMSO): δ163.8, 162.9, 155.7, 152.9, 138.8, 136.4, 134.2, 131.2, 129.8, 
129.5, 127.4, 126.9, 124.0, 121.7, 119.4, 108.2, 107.3, 77.7, 43.1, 42.2, 28.2. 
MS (ESI-) : m/z (%) = 430.3 (100) [M-H]-. 
Exact mass: C25H24N3O4 calc. 430.1767; found 430.1778 
4-(2-Bromobenzyl)amino-N-(4’-boc-aminomethylbenzyl)naphthalimide (6): 
4-Amino-N-(4’-Boc-aminomethylbenzyl)naphthalimide (5) (1.50 g, 3.49 mmol) and 
sodium hydride (60% dispersed in mineral oil, 306 mg, 7.66 mmol) were mixed in dry 
DMF (20 ml). The mixture was stirred for 5 min and then 2-bromobenzyl bromide (870 
mg, 3.49 mmol) was added. The mixture was stirred for 3 h before quenching with water 
(150 ml). The suspension was extracted with ethyl acetate (25 ml, × 3). The organic 
extractions were combined and washed with water (50 ml). After separation, the organic 
solvent was removed on a rotavap and the residue was purified on a silica gel column 
(ethyl acetate/hexane, 1:4). A yellow powder product (840 mg, 40% yield) was obtained. 
1H-NMR (D6-DMSO): δ8.58 (d, 1H, J = 7.2 Hz), 8.43 (d, 1H, J = 8.4 Hz), 8.13 (d, 1H, J = 
8.4 Hz), 7.64~7.61 (m, 2H), 7.49 (d, 2H, J = 8.0 Hz), 7.37 (dd, 1H, J1 = 7.6 Hz, J2 = 1.6 
Hz), 7.30~7.28 (m, 1H), 7.27~7.18 (m, 2H), 6.68 (d, 1H, J = 8.4 Hz), 5.78 (s, 1H), 5.33 (s, 
2H), 4.75 (s, 1H), 4.69 (d, 2H, J = 5.6 Hz), 4.24 (d, 2H, J = 5.6 Hz), 1.43 (s, 9H) 
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13C-NMR (D6-DMSO): δ164.8, 164.2, 156.0, 149.1, 138.0, 137.2, 136.1, 134.7, 133.5, 
131.6, 130.0, 129.8, 129.5, 129.3, 128.1, 127.8, 126.2, 125.2, 123.8, 123.4, 120.6, 111.3, 
105.3, 79.6, 48.3, 44.7, 43.2, 28.6 
MS (ESI+): m/z (%) = 600.5 (100) [M+H]+. 
Exact mass: C32H31BrN3O4 calc. 600.1498; found 600.1504 
4-(2-Dihydroxylboryl-benzyl)amino-N-(4’-boc-aminomethylbenzyl)naphthalimide 
(7): 
4-(2-Bromobenzyl)amino-N-(4’-boc-aminomethylbenzyl)naphthalimide (6) (391 mg, 
0.65 mmol), PdCl2(dppf) (160 mg, 0.20 mmol), bis(neopentyl glycolato)diboron (368 mg, 
1.63 mmol) and KOAc (198 mg, 2.02 mmol) were mixed in a dry flask under N2. 
Anhydrous DMSO (5 ml) was injected into the mixture. The solution was heated at 
80~85 ℃ under N2 for 5 h. Then the solution was cooled down to RT. Water (25 ml) was 
then added to quench the reaction. The solution was extracted with ethyl acetate (25ml, 
× 2). The extractions were combined, washed with water (25ml, × 2) and concentrated 
on a rotavap. The residue was purified on a silica gel column, and the crude product was 
eluted out by ethyl acetate/MeOH = 10:1. The crude product was further purified on two 
20 × 20 cm preparatory TLC plates (ethyl acetate/MeOH = 5:1). The orange fluorescent 
band (Rf = 0.1~0.5) was cut out and extracted with MeOH. Orange color solid product 
was obtained (167 mg, 45% yield). 
1H-NMR (MeOD): δ8.22 (d, 1H, J = 8.0 Hz), 8.04 (d, 1H, J = 8.8 Hz), 7.58 (d, 1H, J = 7.2 
Hz), 7.42 (d, 2H, J = 7.6 Hz), 7.33~7.25 (m, 4H), 7.19~7.16 (m, 3H), 6.17 (d, 1H, J = 8.4 
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Hz), 5.30 (s, 2H), 4.55 (s, 2H), 4.15 (s, 2H), 1.42 (s, 9H) 
 13C-NMR (MeOD): δ167.8, 166.2, 164.7, 158.7, 141.6, 139.5, 138.9, 133.6, 130.9, 
129.4, 129.1, 129.0, 128.8, 128.3, 127.5, 126.4, 119.6, 104.0, 101.8, 80.3, 47.7, 45.0, 
43.8, 30.9, 28.9 
MS (ESI-) : m/z (%) = 564.3 (100) [M-H]-. 
Exact mass: C32H31BN3O6 calc. 564.2306; found 564.2310 
4-(2-Dihydroxylboryl-benzyl)amino-N-(4’-aminomethylbenzyl) naphthalimide (8): 
4-(2-Dihydroxylboryl-benzyl)amino-N-(4’-Boc-aminomethylbenzyl)naphthalimide (7) 
(390 mg, 0.69 mmol) was suspended in CH2Cl2 (12 ml) and TFA (1.2 ml, 15.6 mmol) was 
added in one-shot. The mixture was stirred at RT for 0.5 h and then concentrated on a 
rotavap. The residue was washed with a saturated K2CO3 solution. Then the residue was 
dissolved in methanol and loaded on two 20 × 20 cm preparatory TLC plates. 100% ethyl 
acetate was used to develop first. Later, ethyl acetate/MeOH (5:1) was used to develop 
the plate. The orange fluorescent band (Rf = 0.2~0.3) was cut out and extracted with 
MeOH. An orange color solid product was obtained (210 mg, 66% yield). 
1H-NMR (MeOD): δ8.21 (d, 1H, J = 6.8 Hz), 8.03 (t, 1H, J = 4 Hz), 7.58 (d, 1H, J = 7.2 
Hz), 7.44~7.37 (m, 4H), 7.29~7.25 (m, 4H), 7.17 (t, 1H, J = 7.2 Hz), 6.16 (d, 1H, J = 8.8 
Hz), 5.32 (s, 2H), 4.55 (s, 2H), 3.86 (s, 2H),  
 13C-NMR (MeOD): δ167.8, 166.1, 141.6, 140.2, 138.8, 133.6, 130.9, 129.4, 129.3, 
129.2, 128.9, 127.5, 126.3, 119.4, 103.8, 101.8, 47.9, 45.5, 43.8 
MS (ESI-): m/z (%) = 492.3 (100) [M-H-2H2O+2MeOH]-, 478.3 (70) [M-H-H2O+MeOH]-, 
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464.3 (50) [M-H]-. 
Exact mass: C27H23BN3O4 calc. 464.1782; found 464.1796 
4-(2-Dihydroxylboryl-benzyl)amino-N-(4’-azidoacetyl-aminomethyl- 
benzyl)naphthalimide (9): 
4-(2-Dihydroxylboryl-benzyl)amino-N-(4’-aminomethylbenzyl)naphthalimide (8) (210 
mg, 0.45 mmol), EDCI (170 mg, 0.90 mmol), and azidoacetic acid (91 mg, 0.90 mmol) 
were mixed in anhydrous DMF (10 ml). The mixture was stirred at RT under N2 for 1 h. 
The solution was concentrated by oil pump at 35 °C. The residue was rinsed with H2O 
and then saturated K2CO3 solution. After that, the residue dissolved in ethanol was 
loaded on to two 20 × 20 cm preparatory TLC plates and 100% ethyl acetate was used to 
develop first. Later, ethyl acetate/MeOH (10:1) was used to develop the plate.  The 
orange fluorescent band (Rf = 0.2~0.3) was cut out and extracted with MeOH. An orange 
color solid product was obtained (241 mg, 98% yield). 
1H-NMR (MeOD): δ8.23 (d, 1H, J = 7.2 Hz), 8.06 (d, 1H, J = 8.4 Hz), 7.59 (d, 1H, J = 6.8 
Hz), 7.42 (d, 2H, J = 7.6 Hz), 7.33 (d, 2H, J = 8.0 Hz), 7.27 (t, 2H, J = 7.6 Hz), 7.21~7.17 
(m, 3H), 6.19 (d, 1H, J = 8.8 Hz), 5.30 (s, 2H), 4.55 (s, 2H), 4.34 (s, 2H), 3.88 (s, 2H) 
13C-NMR (MeOD): δ170.1, 167.8, 164.6, 141.5, 139.3, 138.9, 138.2, 133.6, 130.9, 129.4, 
129.2, 128.9, 128.8, 127.6, 126.5, 119.8, 104.3, 101.8, 53.1, 47.5, 44.2, 44.0, 43.8, 30.9, 
18.5 
MS (ESI-): m/z (%) = 547.3 (100) [M-H]-, 561.3 (50) [M-H-H2O+MeOH]-. 
Exact mass: C29H24BN6O5 calc. 464.1782; found 464.1796 
60 
 
 
The M-TTP was synthesized following previously published procedure (Scheme 
3.2).231  
5-[3-(Trifluoroacetamido)-propynyl]-2’-deoxyuridine (10): 
5-Iodo-2’-deoxy uridine (354 mg, 1.0mmol) was dissolved in degassed dry DMF (10 
mL). Copper (I) iodide (38 mg, 0.2 mmol), freshly distilled triethylamine (0.28 mL, 2.0 
mmol) and freshly distilled N-propynyltrifluoroacetamide (453 mg, 3.0 mmol) were added 
later. The mixture was stirred for 30min in dark under N2 protection until everything 
dissolved. Tetrakis(triphenylphosphine) palladium (0) (116 mg, 0.10 mmol) was added 
and the mixture was stirred overnight in dark under N2 protection at r.t.. Then solvent was 
removed and the residue was purified with a silica gel column (dichloromethylene: 
methanol=15:1) to give white solid product (320 mg, 85%) 
1H-NMR (DMSO): δ 2.12 (2H, m), 3.59 (2H, m), 3.79 (1H, d), 4.23 (3H, d), 5.09 (1H, t), 
5.25 (1H, d), 6.10 (1H, t), 8.19 (1H, s), 10.07 (1H, s) 
5-[3-Amino-propynyl]-2’-deoxyuridine (11) 
Compound 10 (250 mg, 0.64 mmol) was dissolved in ammonium hydroxide (5 ml) 
and stirred overnight. The solution was concentrated in vacuo and residual water was 
removed by oil pump for 24h to give product as deep yellow oil (180 mg, 100%) 
1H-NMR (DMSO): δ 2.14 (2H, m), 3.59 (3H, m), 3.82 (1H, m), 3.92 (2H, s), 4.24 (1H, m), 
5.20 (2H, br), 6.10 (1H, t), 8.25 (1H, s) 
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5-[3-(4-Pentynoic amido)-propynyl]-2’-deoxyuridine (12) 
Compound 11 (180 mg, 0.64 mol) was dissolved in dry DMF (5 ml). 4-Pentynoic acid 
(68mg, 0.69mmol) and PyBop (515 mg, 0.99 mmol) were added into the solution under 
ice bath cooling. The mixture was stirred overnight at r.t.. The solvent was removed at 
78 °C in vacuo and the residue was purified with silica gel chromatography 
(dichloromethylene: methanol=15:1) to give pure product as white solid (89 mg, 37%):  
1H-NMR (DMSO): δ 2.11 (2H, dd), 2.28-2.39 (4H, m), 3.53-3.63 (2H, m), 3.79 (1H, quart), 
4.10 (2H, d), 4.22 (1H, m), 5.10 (1H, t), 5.25 (1H, d), 6.11 (1H, t), 8.17 (1H, s), 8.43 (1H, 
t) 
M-TTP: 
All liquid reagents and solvents were freshly distilled to be anhydrous. Compound 12 
(0.15 g, 0.4 mmol) and proton sponge (0.102 g, 0.48 mmol) were dried in vacuo over 
P2O5 overnight and then dissolved in anhydrous trimethylphosphate (0.6 ml) under 
nitrogen. Then the mixture was cooled in an ice bath and POCl3 (44 μL, 0.5 mmol) was 
added dropwise via a syringe with stirring. The reaction mixture was stirred on ice for 2 h 
and then bis-tri-n-butylammonium pyrophosphate (0.98 g) dissolved in DMF (1.6 ml) and 
tri-n-butylamine (0.6 ml) was added in one portion. The mixture was stirred at room 
temperature for 10 min and then triethylammonium bicarbonate solution (0.1 M, pH8, 10 
ml) was added. The reaction mixture was stirred at room temperature for an additional 
hour and concentrated on a rotavap equipped with an oil pump. The residue was purified 
with a DEAE-Sephadex A-25 column using a linear gradient concentration (0-0.6 M) of 
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NH4HCO3 aqueous buffer solution. Monitored with the UV 260nm absorbance, the 
product was eluted out by 0.12–0.15 M NH4HCO3 fraction. The elution was collected and 
lyophilized to give the final product as a white powder (161 mg, 60%). 
31P-NMR (D2O, internal standard: 85% H3PO4): δ -5.34(γ P), -10.14(α P), -18.60(β P) 
1H-NMR (D2O): δ 7.99 (s, 1H), 6.30 (t, 1H), 4.58 (m, 1H), 4.21 (m, 5H), 2.51 (m, 4H), 
2.37 (m, 3H) 
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Scheme 2.1 Synthesis route of M-TTP 
 
NB-TTP: 
4-(2-dihydroxylboryl-benzyl)amino-N-(4’-azidoacetyl-aminomethylbenzyl)naphthalimi
de (7) (10 mg, 0.018 mmol) and M-TTP (10 mg, 0.017 mmol) were mixed in a flask under 
N2. MeOH/H2O (1:1, 200 μl) was injected into the flask later to suspend the mixture with 
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stirring. TBTA (1.7 mg, 0.0033 mmol) and CuBr solution (0.24 mg, 0.0017 mmol) in 50 μl 
DMF were added later. The reaction mixture was sonicated for several minutes and then 
stirred at RT under N2 for 5 h. The reaction was quenched by adding 1 ml of H2O and 
then centrifuged at 13.5k rpm for 15 min. The aqueous supernatant was collected and 
the residue was repeatedly extracted with 100 mM NH4HCO3 buffer pH 8.0 until the 
extraction was no longer deep orange. The aqueous extractions were combined and 
purified by HPLC. The collected fraction was lyophilized into orange color powder. The 
product was washed with MeOH and ice-cold water to remove residual starting material. 
Further purification of NB-TTP was achieved by MeOH precipitation of the saturated 
aqueous solution. A bright red-orange colored powder was obtained as pure product (5 
mg, 25% yield) 
11B-NMR (D2O, internal standard: 15% BF3 in ether): δ29.9 
31P-NMR (D2O, internal standard: 85% H3PO4): δ-5.41 (γ P), -10.31(α P), -18.60(β P) 
1H-NMR (D2O/MeOD = 2:1, Watergate solvent suppression): δ8.17 (d, 1H, J = 7.6 Hz), 
7.91 (d, 1H, J = 9.2 Hz), 7.7~7.5 (m, 2H), 7.1~7.5 (m, 9H), 6.07 (d, 1H, J = 9.2 Hz), 5.95 
(t, 1H), 5.25 (s, 1H), 4.3~4.0 (m, 3H), 2.94 (t, 2H) , 2.47 (t, 2H), 2.16 (t, 2H) 
MS (ESI-): m/z 1032.3 (100) [M-H-2H2O-HPO3]-, 1112.3 (20) [M-H-2H2O]-, 1134.3 
[M-H-3H2O+MeOH]- , 1054.3 [M-H-3H2O+MeOH-HPO3]- 
MS (MALDI linear mode): m/z 1112.57 (100) [M-H-2H2O]-, 1032.97 (45) 
[M-H-2H2O-HPO3]- 
Exact mass: [M-H-2H2O]- C46H42BN9O18P3 calc. 1112.1954; found 1112.1940. 
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2.2 Photo stability test of boronic acid 9: 
Solution of boronic acid 9 (1×10–6 M) in 0.1 M phosphate buffer at pH 7.4 was 
prepared. Using the Time Course function of Shimadzu RF-5301 PC spectrofluorometer, 
excitation wavelength was fixed at 490 nm. Both excitation and emission slits were set at 
5 nm. The fluorescence intensity measurements were taken every 0.3 s at two 
wavelengths (540 and 570 nm) and the fluorescence was monitored for 3600 s [Figure 
2.1 (a)]. The entire fluorescence spectrum was scanned at the end point [Figure 2.1 (b)] 
It can be seen that the fluorescence intensity was constant at both tested emission 
wavelength (540 and 570 nm) and the fluorescence profiles overlap very well after 
constant irradiation for 1 h and 2 h. 
 
(a) 
 
(b) 
Figure 2.1 Photostablity studies of boronic acid 9 in 0.1 M phosphate buffer at pH 7.4 
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2.3 Mass spectrometry 
ESI-MS work was performed using a Waters Micromass Q-TOF micro instrument. 
Data were acquired in either a positive and negative ion mode by syringe pump infusion 
of the sample solutions at a flow rate of 7 µL/min. The MALDI mass spectrometry 
analysis was performed on an Applied Biosystems 4800 plus MALDI TOF/TOF analyzer 
mass spectrometer (Framingham, MA). This instrument is equipped with a 
Diode-pumped Nd:YAG laser at 355-nm. The mass spectra were acquired as an 
average of 3 shots with the same laser intensity attenuator setting (4002 arbitrary unit) 
for all samples. All spectra were recorded on a biomass spectrometer in 
linear-negativemode with delayed extraction. 3-Hydroxypicolinic acid 
(3-HPA)/diammonium citrate (9:1) in water was used as the matrix. A 10:1 matrix:sample 
mixture was prepared, applied to the sample plate as 1 μL drops, and allowed to air dry 
before analysis. 25 kV acceleration voltage was used. A mass range of 1000–10000 was 
scanned. Each spectrum was summed frommultiple spectra at different spots. Proteins, 
such as insulin, thioredoxin, and apomyoglobin, were used as external standards. This 
work was performed by at the Mass Spectrometry Facilities of Georgia State University. 
2.4 High Performance Liquid Chromatography (HPLC) for NB-TTP purification  
The aqueous extractions of crude NB-TTP product with 100 mM NH4HCO3 buffer pH 
8.0 were combined and purified by HPLC (Zobax C18 RP preparatory column, Shimadzu 
LC-10AT VP system). Elution condition: 100 mM NH4HCO3 buffer pH 8.0 /CH3CN (3 
ml/min), 0–10 min (CH3CN 10%), 10–30 min (CH3CN, 10-100%), 30–40 min (CH3CN, 
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100%), 40–45 min (CH3CN, 100-10%), 45–55 min (CH3CN, 10%). Rt = 17.5-22.5 min. 
The collected fraction was lyophilized into orange color powder. The product was 
washed with MeOH to remove residual starting material and extracted again with 100 
mM NH4HCO3 buffer. The extraction was lyophilized again to give the pure product.  
2.5 NB-TTP Fluorescence binding tests 
Solutions of NB-TTP (1×10–6 M) and NB-TTP (1×10–6 M) with D-fructose (0.1 M) were 
prepared in 0.1 M phosphate buffer at pH 7.4, respectively. These two solutions were 
mixed in various ratios to give the desired D-fructose concentrations (10-3 to 0.1 M). 3 ml 
of each mixed solution was used to test the fluorescence intensity several minutes after 
mixing. Eight points were collected for the calculation of the apparent binding constant Ka 
assuming a 1:1 complex formation mechanism. These studies were run in triplicate. 
The binding constants were determined using the following equation: 
I0/(I-I0)=(εB/εB-SKa)*1/[fructose]+ εB/εB-S  
where I0 is fluorescence intensity of NB-TTP solution; I is NB-TTP fluorescence intensity 
upon adding sugar, εB is fluorescence correlation factor of NB-TTP; εB-s is the 
fluorescence correlation factor of NB-TTP-fructose complex; Ka is the binding constant; 
[fructose] is the sugar concentration. 
2.6 Primer extension using the Klenow fragment for MALDI-TOF-MS studies 
14-nt Primer (16 μM), 21-nt template (6.8 μM), Klenow (0.1 units/μl), TTP (0.3 mM) or 
NB-TTP (0.3 mM), and three other dNTPs (0.3 mM each) in total volume of 100 μl were 
incubated at 37 °C for an hour. The prepared DNA was purified using Microcon YM-3 
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centrifugal filter (Millipore Corp.) to remove dNTPs and other low molecular weight 
molecules. The harvested DNA was further purified by 5 M NH4OAc/ethanol precipitation 
(three times) as a way to replace metal ions with ammonium as the phosphate 
counterions.252 The DNA pellet was dissolved in 10 μl for MALDI-TOF-MS analysis. The 
oxidative deborylated NB-DNA sample was prepared by adding 0.25 μl of H2O2 solution 
(100 mM) into 5 μl of NB- DNA solution. MALDI mass spectral results were obtained 
using insulin as the internal standard. 
2.7 PAGE analysis of primer extension 
A mixture of 14-nt primer DNA (50 μM), T4 polynucleotide kinase (0.5 units/μl, 
Biolabs, Inc.) and γ-32P-ATP (0.6 μl, from Perkin-Elmer Corp.) in 12 μl T4 kinase buffer 
solution was incubated at 37 °C for 1 h. The 32P-labeled DNA was purified using 
Microcon YM-3 centrifugal filter (Millipore Corp.) to remove low molecular weight 
molecules. Using a similar primer extension protocol as previously described, the 
32P-labeled primer alone, reaction mixture without enzyme, reaction mixture without 
dNTPs, reaction mixture with both enzyme and natural dNTPs and reaction mixture with 
NB-TTP, the other 3 dNTPs and enzyme were incubated at 37 °C for 1 h. The reactions 
were quenched with 2× DNA loading dye. 3 ul of samples from each reaction were taken 
and run on 15% PAGE at 300V for 3 h. Later, the gel was fixed and dried. Film was 
developed after autoradiography with the dried gel for overnight. 
 
 
68 
 
 
2.8 NB -DNA fluorescence binding tests 
2.8.1 Double stranded NB- DNA binding tests 
Primer (7 μM), Template 0~7 (7 μM), Klenow (0.1 units/μl), NB-TTP (125 μM), and 
three other dNTPs (0.3 mM each) in total volume of 200 μl were incubated at 37 °C for 
an hour. After purification of the DNA through membrane filtration and NH4OAc/ethanol 
precipitation three times, the orange-colored DNA pellet was supposed to be 
quantitatively precipitated out,252 and dissolved in 50 μl of H2O. 45 μl of the NB- dsDNA 
solution was diluted by 4.5 ml 0.1 M phosphate buffer (pH 7.4) to make theoretical 
concentration of 0.5 μM solution. D-fructose was added into the DNA solution with 
concentration increasing from 10-3 to 0.1 M. 1 ml of solution was used to test the 
fluorescence intensity more than 5 minutes after mixing. Each test was triplicated. 
2.8.2 Single stranded NB- DNA binding tests 
Primer (21 μM), Template 0~7 (7 μM), Klenow (0.1 units/μl), NB-TTP (125 μM), and 
three other dNTPs (0.3 mM each) in total volume of 200 μl were incubated at 37 °C for 
an hour. After purification of the DNA through membrane filtration and NH4OAc/ethanol 
precipitation three times, the orange-color DNA pellet was dissolved in 50 μl of H2O. 45 
μl of the NB- ssDNA solution was heated at 90 oC for 1 min, then quickly cooled down in 
ice bath and diluted by 2.5 ml 0.1 M phosphate buffer (pH 7.4) to make theoretical 
concentration of 0.56 μM solution. 0.5 ml of each NB- ssDNA solution was mixed with 0.5 
ml of phosphate buffer (blank), 0.5 ml of D-fructose phosphate buffer solution (0.2 M), 
0.5 ml of D-lactose phosphate buffer solution (0.2 M), 0.5 ml of D-maltose phosphate 
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buffer solution (0.2 M), and 0.5 ml of D-sucrose phosphate buffer solution (0.2 M) 
solution respectively. 1 ml of each NB-ssDNA/sugar solution was tested the fluorescence 
intensity more than 5 minutes after mixing. The fluorescence intensity was divided by 
that of the blank to calculate the increasing fold. Each test was triplicated. 
2.9 HeLa cell sub-culture and fluorescence imaging study 
2.9.1 HeLa cells sub-culture 
The cells have to be sub-cultured or passaged as part of maintenance to prevent over 
growth of the cells. The process is common for any adherent cell line.253 A sterile flask 
was taken, added with 19.5 ml of fresh medium (DMEM + 10% Normal FBS + 1% 
Penicillin/Streptomycin) and incubated in a CO2 incubator at 37 oC, 5% CO2 and 90% 
relative humidity. 
T-75 flask with 80-85% confluent culture was taken out from the CO2 incubator and 
the spent medium was removed. The cells were washed for 2 min with10ml of DPBS 
twice. 2-3 ml of trypsin (0.25%, from Mediatech, Inc) was add to the flask and incubated 
for 2 min in a CO2 incubator at 37oC, 5% CO2 and 90% relative humidity. After 2-3 mins, 
the flask was removed from the incubator and 4ml of fresh medium was added to 
neutralize the effect of trypsin. The suspension was mixed gently to break the clumps. 
0.5ml of the suspension was drawn and added into the flask with pre-warmed fresh 
medium. The flask was kept for incubation in a CO2 incubator at 37 oC, 5% CO2 and 90% 
relative humidity. 
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2.9.2 HeLa cells fluorescence imaging study 
A T-75 flask of 80% confluent HeLa cell line was treated with 3 ml of trypsin (0.25%, 
from Mediatech, Inc). Cover slips were sterilized by treatment with 70% ethanol and then 
exposed to UV light in the laminar airflow. The sterilized cover slips were carefully placed 
into the 24-well plate and 500uL of cell suspension was added onto the cover slip in each 
well. The plate was left in the incubator at 37 oC, 5% CO2 and 86% humidity until the cell 
line reached 50-60% confluence (approximately 24hr).  
After incubation, test fluorescence compound dissolved in growth medium was added 
to the cells in the 24-well plate at required concentrations. The plate was left in the 
incubator at 37 oC, 5% CO2 and 86% humidity. After incubation for 24 hr, medium from 
each well was removed and the cells were gently washed with 500 ul PBS twice. 200 ul 
of ice-cold methanol was added to each well and incubated at r.t. for 5 mins. Then 
methanol was removed and the cells were washed again with 500 ul PBS twice. 
The cover slips were carefully removed from the wells using a forceps and placed an 
inverted position on slides with the cells side facing the slide. The coverslips were dried 
with Kimwipes and the edges were sealed using clear nail polish. The slides with 
coverslips on top were inverted and observed under a Zeiss Axiovert 400M inverted 
epifluorescence microscope using the 40X oil lens with Immersol 518F oil. The filter 
cubes were switched to FITC (495/520) channel and the images were captured using 
AxioVision Rel 4.6 program. 
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2.9.3 HeLa cells crude protein and genomic DNA extraction: 
The procedures were following the technical manual of Wizard genomic DNA 
purification kit by Promega Corporation. The cultured cells were first trypsinized and 
transferred to a 1.5ml microcentrifuge tube. The cells were pelleted by centrifuging at 
13,000 × g for 10 sec. The supernatant was removed. The pellet was washed with 200 μ
L PBS and centrifuged again. The pellet was added with 600 μL of Nucleic Lysis 
Solution and pipette until no visible cell clumps remain. 3 μL of RNase Solution was 
added into the lysate solution and mixed by inverting the tube 2-5 times. The mixture was 
incubated at 37 °C for 30 min and then cooled down to r.t. 200 μL of Protein 
Precipitation Solution was added into the mixture and the mixture was vortexed 
vigorously for 20 sec. The sample was chilled on ice for 5 min. The protein was 
precipitated by centrifuging at 13,000 × g for 4 min. The tight white pellet was collected at 
crude protein extraction. It was dissolved in 1 mL of PBS and directly subjected for 
fluorescence test. 
  The supernatant was transferred to a clean 1.5 mL microcentrifuge tube containing 
600 μL of isopropanol. The solution was gently inverted until white thread-like strands of 
DNA form a visible mass. The suspension was centrifuged at 13,000 × g for 1 min and 
the supernatant was removed. The DNA white pellet was added with 600 μL of 70% 
ethanol. The mixture was gently inverted several times to wash the DNA and then 
centrifuged at 13,000 × g for 1 min. The supernatant was removed and the pellet was 
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air-dried for 15 min. The DNA was rehydrated by incubating with 100 μL of DNA 
Rehydration Solution at 65 °C for 60 min. The solution was diluted by PBS into 1 mL 
solution and subjected for fluorescence test. 
2.9.4 Isolation of HeLa cell nuclei 
The procedure was following the method described by Gonzalez-Lazaro.254 The 
cultured HeLa cells were trypsinized and washed with PBS. The cell pellet was 
suspended in 1 mL of solution 1 (0.32 M sucrose, 0.002 M MgCl2, 0.001 M K2HPO4, pH 
6.8) and centrifuged at 1000 × g for 7 min. The supernatant was removed and the pellet 
was resuspended in 1 mL of solution 2 (0.01 M NaCl, 0.001 M K2HPO4, pH 6.8) and 
incubated at 4 °C for 15 min. The cells were then centrifuged at 800 × g for 10 min. The 
supernatant was removed and the pellet was suspended in 1 mL of solution 3 (0.32 M 
sucrose, 0.001 M MgCl2, 0.3% Triton X-100, 0.001 M K2HPO4, pH 6.2-6.4). The cells 
were lysed through a 22-gauge needle (10 passes). The partially lysed cells were then 
centrifuged at 800 × g for 10 min and the supernatant was discarded. The pellet was 
suspended in 1 mL of solution 3 and lysed through a 22-gauge needle (10 passes) again. 
The lysed cells were centrifuged and the pellet was washed with solution 1. All 
instrument and solutions were pre-cooled at 4 °C before usage and the experiment was 
carried out at r.t. as quick as possible.  
 
73 
 
 
 
3. SYNTHESIS AND ENZYMATIC STUDIES OF NAPHTLIMIDE-BASED BORONIC 
ACID-CONJUGATED TTP (NB-TTP)  
3.1 Introduction 
Our lab has had a long-standing interest in using the boronic acid moiety, which is 
known to interact with diols/carbohydrates, fluoride, cyanide, and other 
nucleophiles/Lewis bases,122,200 as a recognition group for sensing and other 
applications.123 Recently, we have reported the synthesis of a boronic acid-modified 
thymidine triphosphate (B-TTP),231 its enzymatic incorporation into DNA, and discussed 
the feasibility of using it in DNA aptamer selection. Along this line, we desire to 
incorporate a fluorescent boronic acid into DNA that has the following properties: (1) the 
excitation and emission wavelengths are longer than the λmax of nucleobases; (2) shows 
fluorescent property changes upon carbohydrate binding; (3) is stable under PCR 
conditions; (4) is stable under copper-mediated “click” conditions with DNA;255-256 and (5) 
is relatively easy to synthesize.  
To synthesize another B-TTP with improved features such as intrinsic fluorescence 
emission at long-wavelength, 4-amino-1,4-naphthalimide (Nap) was chosen as the 
fluorophore after careful consideration and evaluation. Before, Heagy and coworkers 
reported a series of 1,4-naphthalimide based N-phenylboronic acids.177 They were 
promising in the sense of their long wavelength emission (550 nm) and good water 
solubility, but were limited in applications because their fluorescence decreases upon 
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sugar binding. Mohr and coworkers developed one 1,4-naphthalimide based 
carbohydrate sensor with a terminal boronic acid at the 4-amino position linked through 
an aliphatic chain.257 The designed 1, 5-relationship of the boronic acid with the nitrogen 
at the aliphatic linker was proposed to interact through B-N bond formation to modulate 
the PET (photoinduced electron transfer) system that influence the fluorescence 
properties.139 An alternative hydrolysis mechanism was also proposed to explain the 
same phenomenon by the Wang group.172 The Mohr boronic acid sensor showed a 
maximum of 130% fluorescence intensity increase upon D-fructose addition (λex: 410 nm, 
λem: 530 nm, pH 7.15). Recently, a systematic study of novel 
4-amino-1,4-naphthalimide-derived phenylboronic acids was carried out by our group. A 
comprehensive mechanistic investigation of the fluorescence changing was also 
performed.170,258 In this case, boronic acid was directly functionalized in 1,5-relationship 
with the nitrogen of the 4-aniline group (Figure 3.1). Sensor 1a showed 2.5-fold and 
1.1-fold fluorescence intensity increase upon fructose and glucose binding, respectively 
(λex: 493 nm, λem: 570 nm, 0.1% MeOH in 0.1M phosphate buffer, pH 7.4).258 
Interestingly, sensors 1b-1c with modification at the para- position by different 
electron-withdrawing or electron-donating groups didn’t result in much changes in 
carbohydrate binding constants and fluorescence intensity increases. However, 
correlation of the boronic acid pKa values and binding indicated a general Hammett 
correlation trend with different substituents.170 It was proposed that an excited-state 
internal charge-transfer (ICT) mechanism was responsible for the fluorescence intensity 
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increase accompanying decreased solvent polarity, increased pH value or upon 
carbohydrate binding. It was suggested that through stabilization of the excited-state 
charge separation by the negatively charged boronate, bathochromic shift of the UV λmax 
value with increased absorption intensity could at least partially contribute to the 
increased fluorescence emission intensity. In addition, the carbohydrate-boronate ester 
formation would limit the rotation around C-N bond due to steric hinderance, which could 
lead to a higher fluorescence quantum yield and thus enhanced fluorescence intensity. 
Also, the boronate ester formation could increase the B-N distance, which would lessen 
the stabilization effect of boronate on the excited-state charge–transfer species, and 
caused the hypsochromic shift of both the UV λmax value and fluorescence emission 
wavelength upon carbohydrate addition. The increased B-N distances upon 
carbohydrate binding were supported by molecular modeling calculations using density 
function theory (DFT) in a polarizable continuum model (PCM). 
N OO
HN
B
OH
OH
X
1a X = H
1b X = OMe
1c = COOMe
1d = F
 
Figure 3.1 4-Amino-1,4-naphthalimide-derived phenylboronic acids by Wang 
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Through tethering the boronic acid sensor 1a to the 5-position of TTP, it is expected 
that the fluorescent TTP analogue could yield DNA aptamers with not only high affinity 
and selectivity against carbohydrate analytes, but also fluorescence changes in the 
visible range as reporting signals.  
3.2   Results and discussion 
3.2.1 Synthesis of NB-TTP 
The NB-TTP design strategy (Figure 3.2) was similar as the previous one,231 by 
choosing 4-amino-1,4-naphthlimide (Nap) as the fluorphore, benzyl boronic acid as the 
carbohydrate-binding moiety, and a terminal alkyne at TTP 5-position (M-TTP, Figure 
1.15) for linkage. The final coupling step was designed through Cu(I)-catalyzed 
alkyne-azide cyclization (CuAAC),247,249,259 which is a commonly used and efficient way 
of linking a large fluorophore group to biomolecules.  
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Figure 3.2 NB-TTP design strategy 
 The naphthlimide-based boronic acid (NB) 9 was synthesized in eight consecutive 
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steps starting from reduction of 4-(hydroxymethyl)benzonitrile with LiAlH4, followed by 
Boc- protection of the -NH2 group and methansulfonation of the –OH group to give 4. 
Alkylation of 4-amino-naphthalimide with 4 and 2-bromobenzyl bromide sequentially 
yields the aromatic bromide 6(aNap), which was subjected to Pd(II) catalyzed borylation 
in the subsequent step. The obtained boronic acid 7 (NB7) was deprotected of the Boc- 
group using TFA and then coupled with azidoacetic acid through EDCI to give boronic 
acid 9 with a terminal azide linker (Scheme 3.1).  
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i ii iii iv v
vi vii viii
i) LiAlH4, THF reflux, 98%; ii) di-t-butyl dicarbonate, Et3N, THF, 94%; iii) MsCl, Et3N, THF, 96%; iv) NaOMe, 
4-amino-naphthalimide, DMF, 90%; v)NaH, 2-bromo-benzyl bromide, DMF, 40%; vi) Bis(neopentyl glycolato) 
diboron, PdCl2(dppf), KOAc, DMSO, 45%; vii) TFA, CH2Cl2, 66%; viii) azidoacetic acid, EDCI, DMF, 98%
2 3 4 5
6 7 8 9
Scheme 3.1 Synthesis route of naphthalimide-based boronic acid (NB)9 
 
78 
 
 
During the experiment, it was observed in Step vii and viii that low yields were 
achieved with large amount of insoluble solid. Normally, both Boc- deprotection by TFA 
and EDCI coupled amide formation should give close to quantitative yield. Later 
treatment of the solid with saturated K2CO3 solution made it soluble in MeOH. It was 
revealed by 1H-NMR their identity as the boronic acids 8 and 9, respectively. Thus, the 
solubility of 4-amino derived phenylboronic acids of naphthlimide was greatly affected by 
pH. Acidic condition created by TFA or azidoacetic acid could significantly decrease the 
boronic acid solubility.  
Before coupling boronic acid 9 with M-TTP, we performed a photostability test of it 
because photo bleaching is a common problem faced by many fluorophores.260-261  It 
can be seen that the fluorescence intensity was constant at both tested emission 
wavelength (540 and 570 nm) and the fluorescence profiles overlap very well after 
constant irradiation for 1 h and 2 h (Figure 2.1). Thus, photo stability should not be a 
major issue in this case, which further improves the chance of success for this type of 
boronic acid. 
In the coupling step, TBTA (tris-(benzyltriazolylmethyl)amine) was added as a Cu(I) 
ligand to accelerate the reaction rate and also protect the product from metal-catalyzed 
degradation (Scheme 3.2).255,262-264 Due to the poor solubility of boronic acid under acidic 
condition, extraction of NB-TTP from reaction mixture was achieved using basic 0.1M 
NH4HCO3 buffer (pH 8.0). After HPLC purification of the buffer extraction, the lyophilized 
NB-TTP product was washed with MeOH and ice-cold water to remove the residual 
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amount of starting material 9. Characterization of NB-TTP with 1H-NMR in pure D2O was 
not successful due to the continuous peaks in aromatic region (δ: 7-9 ppm) which were 
indistinct. The reason was assumed to be due to the naphthlimide aromatic stacking 
(π-π stacking) in aqueous environment. High quality of 1H-NMR spectrum data were 
obtained by dissolving NB-TTP in a mixed solvent of D2O/MeOD (2:1) with Watergate 
solvent suppression method. Surprisingly, NB-TTP had very low solubility in water 
despite of its highly hydrophilic triphosphate moiety. Using UV absorbance method, it 
was determined that the NB-TTP saturated aqueous solution had a concentration of 
lower than 170 μM. This is also good evidence to support the theory of naphthlimide 
stacking in aqueous solution. However, it was also observed that in the presence of 
MeOH the water solubility of NB-TTP was further decreased. In fact, dissolving NB-TTP 
in water followed by MeOH precipitation served as an excellent way for its purification. 
Thus, NB-TTP behaved as an amphiphilic molecule with one end of hydrophobic 
fluorophore and the other end of hydrophilic nucleoside triphosphate. In practice, 
vigorous shaking of the NB-TTP aqueous solution resulted in foaming similar to soaps or 
other detergent solutions. The identity of NB-TTP was also confirmed with mass 
spectrometry. With a calculated [M-H]-1 of 1149.65, m/z: 1112.2 was obtained as the 
major peak in negative mode of ESI-MS, which corresponded to the fragment ion of 
[M-H-2H2O]-. While it is normal for boronic acid or nucleoside triphosphate to lose one 
molecule of H2O in mass spectrum, it is not surprising to see two molecules of H2O were 
lost in a boronic acid- nucleoside triphosphate conjugate molecule. 
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Scheme 3.2 Synthesis of NB-TTP using CuAAC 
 
Since the newly designed NB-TTP was featured with its unique fluorescence 
properties change upon carbohydrate binding, fructose was chosen as the model 
molecule for validation test before its incorporation into DNA sequences. Hence, as 
shown in Figure 3.3 (a), the fluorescence intensity of NB-TTP increased upon D-fructose 
addition in a concentration dependent fashion (λex: 490 nm, λem: 540 nm). Thus, the 
binding constant Ka was calculated using the equation described in Section 2.5 in 
Chapter 2.265 The Ka was determined to be 73 ± 5 M-1 from triplicate experiments. Such 
results demonstrate that even after conjugation with a nucleobase (thymidine), the 
naphthalimide-based boronic acid (NB) maintains its ability to change fluorescent 
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properties upon sugar binding. 
(a) 
 
(b) 
Figure 3.3 Fluorescent binding tests of NB-TTP with D-fructose (λex: 490 nm) in 0.1M 
phosphate buffer (pH 7.4) 
 
3.2.2 Enzymatic studies of NB-TTP 
Next we studied whether this NB-TTP can be incorporated into DNA in an 
enzyme-catalyzed reaction. In this study, NB-TTP was incorporated into a DNA 
sequence of 14-nt primer (5’-TAGCGGGTTGCTGG-3’, calc. MW: 4350.8) 
complemented with a 21-nt template (5’-GGTTCCACCAGCAACCCGCTA-3’, calc. MW: 
6336.2) through Klenow Fragment catalyzed primer extension. The primer and template 
sequences were designed in such a way that the first base to be incorporated is a T, 
which led to a “none-or-all” case in the extension. The results were analyzed by both 
MALDI mass spectrometry and gel electrophoresis methods. 
In the control reaction, full extension of the primer using natural dNTPs yielded a DNA 
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with m/z: 6520.4 (calculated [M+H]+: 6519.3) as the major product peak in MALDI-MS 
(Figure 3.4). The minor peak of m/z: 6850.6 could have resulted from a non-specific 
extension with an extra nucleotide. In the NB-TTP (replacing TTP) reaction, primer 
extension yielded a DNA with m/z: 7142.8 as the major product peak (Figure 3.5). Since 
the calculated [M+H]+ is 7186.5, it is reasonable to assign the detected peak as the 
deborylated NB-DNA sequence (calc. [M+H-HBO2]+: 7142.5). In order to further 
determine whether the deborylation happened during primer extension reaction or during 
ionization in MALDI-MS, another sample of NB-TTP extension DNA sequence treated 
with H2O2 was analyzed under same condition. In this case, a new peak of m/z: 7160.6 
was observed (Figure 3.6), which is assigned as the oxidative deborylated NB-DNA 
sequence (calc. [M+H-HBO]+: 7158.5). Thus, it was concluded that the boronic acid of 
NB-TTP was intact after incorporation into the DNA sequence and deborylation 
happened during the ionization process, which is very common with arylboronic acids. 
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Figure 3.4  MALDI-TOF-MS of primer extension using natural TTP 
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Figure 3.5 MALDI-TOF-MS of primer extension using NB-TTP 
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Figure 3.6 MALDI-TOF-MS of primer extension using NB-TTP, followed by treatment 
with H2O2 
The DNA from primer extension using NB-TTP was also studied using gel 
electrophoresis. The 14-nt primer was labeled with 32P at the 5’-end using γ-32P-ATP and 
T4 kinase (Figure 3.7, Lane 1). Negative control reactions without the Klenow fragment 
(Figure 3.7, Lane 2) and without dNTPs (Figure 3.7, Lane 3) showed no full length DNA 
sequence. On the other hand, positive control reactions in the presence of both the 
enzyme and natural dNTPs (Figure 3.7, Lane 4) showed full length DNA. The shorter 
length of DNA in the Lane 3 without dNTPs could result from the 3’→5’ exonuclease 
activity of Klenow fragment.266 Primer extension using NB-TTP and three other natural 
dNTPs gave a full length of DNA sequence (Figure 3.7, Lane 5). Its smear band could be 
due to the interaction of the boronic acid moiety with the gel matrix or the DNA 
conformation disrupted by the large naphthalimide moiety. Thus, both mass 
spectrometry and gel electrophoresis results indicated that NB-TTP was recognized by 
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DNA polymerase as a substrate and incorporated into DNA. 
                           1    2    3    4    5 
 
Figure 3.7 Primer extension analyzed on 15% PAGE:  
1) primer only; 2) reaction without enzyme; 3) reaction without dNTPs; 4) reaction with 
natural dNTPs; 5) reaction with NB-TTP and other dNTPs 
3.3 Conclusion 
In conclusion, we have successfully synthesized a naphthalimide-based boronic 
acid modified TTP (NB-TTP) in totally 13 steps. The chosen boronic acid moiety 
displayed long-wavelength fluorescence emission, good photo stability, and fluorescent 
properties changes upon carbohydrate binding. The features were retained after 
conjugating the boronic acid to TTP moiety. Enzymatic studies of the NB-TTP showed 
that it can be successfully recognized by DNA polymerase such as the Klenow fragment 
as the substrate. The NB-TTP incorporated DNA sequences were analyzed by both 
mass spectrometry and gel electrophoresis methods, which both gave positive results 
that supported each other. 
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4. FLURESCENCE PROPERTY STUDIES OF NB-TTP-MODIFIED DNA 
4.1 Introduction. 
In addition to their critical roles in storing genomic information, DNA molecules are 
also very important in the development of aptamers,267-269 nanoelectronic assemblies,270 
nanosensors,271 nanoclusters,272-273 nanocomputing,274-275 and DNA rotary machine,276 
to name a few.277 DNA functionalization brings in additional properties for broadened 
applications.  For example, gold-nanoparticle functionalized DNA assemblies have 
been used in sensor development with extraordinary sensitivity;278 and side-chain 
functionalized DNA has been used in aptamer selection with improved affinity and 
properties.279-283     
Boronic acid-modified DNA may have applications in carbohydrate and glycoprotein 
sensing as well as the construction of other DNA assemblies with unique properties. For 
example, nucleic acid and peptide-templated multi-boronic acid compounds are artificial 
lectin mimics;227,230,284-285 boronic acid-containing compounds have been used in the 
preparation of polymers with reversible properties;286-289 boronic acid-modified proteins 
can be used as lectin mimics with improved affinity and for protein purification;233 and 
boronic acid-containing polymers have been used for the development of 
glucose-sensitive insulin release systems.290-291 Among them, boronic acid sensors with 
both nucleic acid- and peptide-backbone structure were created in a combinatorial 
fashion as described in introduction part. The difference between them lies in that nucleic 
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acid-base boronolectins (NBLs) are selected from a random pool of molecular library, 
while peptide-based boronolectins (PBLs) are constructed in a pattern-based detection 
array method that mimics mammalian olfactory sensing system. It is almost certain that 
the biomolecular backbone structure and the boronic acid positioning would affect or 
even determine the glycan binding affinity and selectivity. Therefore, fundamental studies 
of such in NBLs are quite important. However, so far no such studies have been reported, 
probably because that the selection nature of the SELEX method doesn’t require too 
much detailed structural information. However, for the purpose of rational construction of 
NBLs with intrinsic fluorescence, such information could be very critical. For example, 
due to the self-quenching of fluorophores and possible destabilization of sensor-target 
complex by fluorophores, increasing the labeling density on nucleic acid backbone 
doesn’t necessarily lead to higher fluorescence intensity and binding affinity.292-295    
4.2 Results and discussion  
4.2.1 Double stranded NB-DNA binding tests 
After incorporating NB-TTP into the DNA sequence, we were interested in studying 
whether sugar addition to the DNA solution would still cause fluorescence property 
changes. Since dNTPs and oligonucleotides are known to quench fluorescence,296-298 
the retention of NB-TTP’s fluorescent property in DNA was uncertain. The DNA was 
synthesized in the same method of using Klenow fragment. For every full-length double 
stranded DNA, only one NB-TTP was incorporated for 14nt-primer extension with the 
21-nt template. After purification with membrane filtration and ethanol precipitation, the 
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NB-DNA was dissolved in 0.1M phosphate buffer (pH 7.4) to make a 5 μM solution, 
which was based on the theoretical yield of DNA synthesis. Fructose concentration was 
increased from 1 to 100 mM. The fluorescence intensity of NB-DNA increased by about 
1.5-fold upon fructose addition (λex: 490 nm, λem: 540 nm) (Figure 4.1). Hence, it showed 
that even after incorporation into DNA sequence, the boronic acid fluorescence 
properties were still well retained. This is the very first example of side-chain 
functionalized DNA showing intrinsic fluorescent property changes upon sugar binding. 
Similar modified DNA will be very useful in the synthesis of DNA molecules/assemblies 
for various applications including sensing of carbohydrates, glycolipids, and 
glycoproteins.  
 
Figure 4.1 Fluorescent binding tests of NB-DNA (0.5 μM) with D-fructose in 0.1M 
phosphate buffer (pH 7.4) 
 
Based on preliminary NB-DNA fluorescence binding studies, more DNA sequences 
are designed to further analyze factors affecting DNA fluorescent properties. To minimize 
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the changes of the DNA sequences, Templates 1-7 were designed in a way of having two 
adenosine on the 5’-end end separated by 0-6 bases while the rest of bases were kept 
the same (Table 4.1). The 21nt-template used for previous enzymatic studies were 
designated as Template 0 for control. Thus, for primer extensions, two NB-TTPs would 
be incorporated to the 14nt-primer with 0 to 6 bases of distance spacing. After that, the 
double stranded bisboronic acid NB-DNA would be tested of its fluorescence properties 
with the model carbohydrate fructose. 
Primer 3’-GGTCGTTGGGCGAT-5’
Template 0 5’-GGTTCCACCAGCAACCCGCTA-3’
Template 1 5’-GGTTCCAACCAGCAACCCGCTA-3’
Template 2 5’-GGTTCACACCAGCAACCCGCTA-3’
Template 3 5’-GGTTACCACCAGCAACCCGCTA-3’
Template 4 5’-GGTATCCACCAGCAACCCGCTA-3’
Template 5 5’-GGATTCCACCAGCAACCCGCTA-3’
Template 6 5’-GAGTTCCACCAGCAACCCGCTA-3’
Template 7 5’-AGGTTCCACCAGCAACCCGCTA-3’
Table 4.1 Designed DNA template sequences for primer extension reactions 
 
Before the carbohydrate-binding test, it was necessary to verify the NB-TTP 
enzymatic incorporation efficiency again. Even thought previous chapter has already 
demonstrated that single NB-TTP could be successfully incorporated through enzymatic 
DNA polymerization, the bulkiness of the first incorporated naphthalimide moiety on DNA 
could impose a possible steric hinderance to the incorporation of the second NB-TTP. 
Fortunately, from the gel electrophoresis results, it can be seen that full-length 
extensions were achieved with all the DNA templates as the major bands for each lane 
90 
 
 
(Figure 4.2). Interestingly, the positive control using a NB-TTP/natural TTP mixture 
showed two fully extended DNA bands with Template 1(Figure 4.2, Lane 3). Due to the 
larger molecular weight of NB-TTP than that of TTP, the faster moving band could be 
assigned as full-length DNA of incorporation of two TTP while the slower moving band 
could be full-length DNA with the incorporation of at least one NB-TTP. The smear of the 
full length NB-DNA bands (Figure 4.2, Lane 4-10) were probably due to the interactions 
of boronic acid with gel matrix or the DNA conformation disrupted by the large 
naphthlimide moiety, which corresponded well with previous enzymatic study PAGE 
results (Figure 3.8). 
                1   2   3   4   5   6   7  8   9  10 
 
Figure 4.2 15% PAGE analysis of primer extensions with Templates 1-7  
1) primer only; 2) reaction without dNTPs; 3) Template 1 extension with NB-TTP +TTP; 4) 
Template 1 extension with NB-TTP; 5) Template 2 extension with NB-TTP; 6) Template 3 
extension with NB-TTP; 7) Template 4 extension with NB-TTP; 8) Template 5 extension 
with NB-TTP; 9) Template 6 extension with NB-TTP; 10) Template 7 extension with 
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NB-TTP 
 
The same model carbohydrate, fructose, was chosen as the model for the fluorescent 
property tests. Double stranded NB-DNA (NB-dsDNA) sequences were generated 
through primer extension reactions with primer/template ratio of 1:1 and no heat 
denaturation before the binding tests. Template 0 was used as the control sequence. 
Fluorescence intensity increases of the various NB-dsDNA sequences upon addition of 
0.1 M fructose examined. From the testing results (Figure 4.3), it could be seen that DNA 
5 showed significantly higher fluorescence intensity increase than the control (DNA 0), 
while DNA 7 showed lower fluorescence increase than the control. Meanwhile, the 
comparison of any other two DNA sequences showed no significant differences due to 
the relatively large experimental errors. Therefore, it indicates at least to some extent 
that the number of boronic acids, the distance spacing between them and the DNA 
sequence do contribute to difference observed in binding. However, those DNA 
sequences were not purposely designed to have significant intrinsic difference in 
fructose binding pattern. This is only a preliminary proof-of-concept experiment study.  
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Figure 4.3 Fluorescent binding tests of NB-dsDNA (Template 0~7) with D-fructose (λex: 
490 nm) in 0.1M phosphate buffer (pH 7.4) 
 
 
4.2.2 Single stranded NB-DNA binding tests 
For the sequence-dependent fluorescence studies of the single stranded DNA, three 
disaccharides, lactose, maltose and sucrose were chosen as the model carbohydrates. 
Single stranded NB -DNA (NB-ssDNA) was created through primer/template ratio of 3:1 
and heat denaturation before binding. It was expected that the bis-boronic acid on DNA 
backbone would have more discrimination towards disaccharides with relatively larger 
molecule and the ssDNA could provide more flexibility in the recognition process. The 
test results (Figure 4.4) showed that DNA 1 and DNA 5 have significant preference of 
lactose to maltose and sucrose while others didn’t. In addition, DNA 5 still showed higher 
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fluorescence intensity increase upon fructose binding than DNA 0 and DNA 7, which was 
similar to the result of dsDNA binding tests (Figure 4.3). Thus, even though the 
differences between the signal intensity increase are relatively small (<30%), they were 
indeed reproducible results. Of course, the nature of boronic acid itself still played the 
major role in carbohydrate recognization in this case, as compared to the effect of DNA 
sequences. 
 
Figure 4.4 Fluorescent binding tests of NB-ssDNA with carbohydrates (λex: 490 nm) in 
0.1M phosphate buffer (pH 7.4) 
 
4.2.3 Optical Properties Comparison Between Naphthalimide (Nap), aNap, NB, 
NB-TTP, NB- dsDNA and NB-ssDNA 
Throughout the whole process of systematic modification of the fluorphore 
4-amino-1,8-naphthalimide (Nap), the optical properties of Nap has been changed along 
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each modification step (e.g. λmax and Abs of UV absorbance, λmax and emission intensity 
of fluorescence). Thus, it would be necessary to evaluation the optical effect of each 
modification step. Thus, alkylated 4-amino-1,8-naphthalimide (6, aNap), NB (7), NB-TTP, 
NB-dsDNA0, NB-TTP-dsDNA5 and NB-TTP-ssDNA5 were chosen to evaluate the effect 
of alkylation, borylation, TTP conjugation, DNA incorporation, on the optical properties of 
Nap (Table 4.2). 
 
  Nap aNap (6) NB(7) NB-TTP NB- 
dsDNA0
NB- 
dsDNA5 
NB- 
ssDNA5
UV λmax 434±1 445±1 490±1 495±1 473±1 468±1 470±1 
UV Abs at λmax 
0.022± 
0.001 
0.013±
0.001 
0.020±
0.001 
0.028±
0.001 
0.012±
0.001 
0.019±
0.001 
0.019±
0.001 
Fluorescence  
λmax 
541±1 529±2 574±1 572±1 531±3 535±1 533±2 
Fluorescence 
Intensity at λmax 
480±6 186±4 235±8 478±11 878±102 610±23 852±58
Integrated 
Fluorescence 
Intensity 
35241± 
387 
13128± 
156 
16838± 
537 
36693± 
786 
71971± 
7430 
54586± 
2035 
72029± 
4917 
Quantum yield (Φ) 
0.013± 
0.004 
0.008± 
0.003 
0.007± 
0.002 
0.011± 
0.003 
0.049± 
0.015 
0.023± 
0.007 
0.031± 
0.009 
Table 4.2 Optical effect of Nap modifications 
(Experiments in triplicate were conducted in 0.1M phosphate buffer pH 7.4, with 0.01% DMSO (for Nap 
and aNap), or 0.01% MeOH (for NB(7)); [Nap] = [aNap] = [NB] = [NB-TTP] = 2 μM; NB-DNA was prepared 
in the same way as for binding tests, theoretical [NB-dsDNA0] = [NB-dsDNA5] =[NB-ssDNA5] = 1.4 μM) 
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  From the results listed in Table 4.2, it can be seen that the magnitude of the intensity 
increase of both UV absorbance (2-fold) and fluorescence (3-fold) were decreased after 
alkylation of Nap. Besides, alkylation of Nap resulted in a red-shift by about 10 nm in its 
UV λmax and a blue-shift by about 10 nm in fluorescence λmax. In contrast, the borylation 
of aNap increased both the UV (1.5-fold) and fluorescence (1.3-fold) intensities, while at 
the same time resulted a λmax red-shifted of about 40 nm in both UV and fluorescence, 
Conjugation of NB to TTP moiety didn’t affect UV significantly, but increased the 
fluorescence intensity by about 2-fold. Such results indicated that increasing 
hydrophobicity (alkylation) of Nap could lead to a decrease in both UV and fluorescence 
intensities, while increasing hydrophilicity (borylation and TTP conjugation) could lead to 
UV and fluorescence intensity increases (Fig 4.5).  
 
Figure 4.5 Fluorescent profiles of Nap, aNap, NB and NB-TTP at 2 μM in 0.1 M 
phosphate buffer pH 7.4 with 0.01% DMSO (for Nap and aNap) or 0.01% MeOH (for 
NB(7))  
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After chemical modification, the optical effect of DNA incorporation of NB-TTP was 
studied. Using DNA sequence 0 with only one T incorporation, it was surprising that the 
fluorescent intensity of NB-TTP increased by more than 2-fold after DNA incoporation. 
This could be partially due to the further increased hydrophilicity of NB. Both UV and 
fluorescence λmax blue-shifted (20 nm for UV, 40 nm for fluorescence) after DNA 
incorporation. It should also be noted that the quantum yield of NB-TTP also increased 
by more than 3-fold after incorporation into dsDNA0. However, NB-TTP incorporation 
into DNA sequence 5 with incorporation of two T bases didn’t increase the fluorescent 
intensity further. Instead, it was decreased by 1.25-fold as compared to that of 
NB-dsDNA0. This phenomenon was probably due to the self-quenching effect of the two 
neighboring NB moieties on the same dsDNA sequence. This assumption was further 
supported by the fact that the fluorescent intensity of NB-ssDNA5 was 0.4-fold higher 
than NB-dsDNA5, probably because of decreased self-quenching effect on more flexible 
ssDNA backbone. The fluorescent profile comparison of NB-TTP DNA incorporation is 
shown in Fig 4.6.      
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Figure 4.6 Fluorescent profiles of NB-TTP (2 μM), NB-dsDNA0, NB-dsDNA5 and 
NB-ssDNA5 (1.4 μM) in 0.1 M phosphate buffer pH 7.4  
 
In all, the effect of chemical modification on fluorphore Nap was tested and evaluated. 
The general trend is that increasing hydrophobicity of Nap would decrease its 
fluorescent intensity, while increasing its hydrophilicity would increase its fluorescent 
intensity. The self-quenching effect of two neighboring NB on the same DNA backbone 
was observed, and the effect could be partially decreased by melting dsDNA into ssDNA. 
 
4.3 Conclusion  
In conclusion, the enzymatic activity of NB-TTP as DNA polymerase substrate has 
been further confirmed by gel electrophoresis. Even for two NB-TTPs to be continuously 
incorporated, full-length DNA polymerization was obtained. Furthermore, fluorescent 
binding studies indicated that binding affinity or selectivity of DNA-based boronic acid 
sensors toward carbohydrates could indeed be affected by the number of boronic acid 
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moieties, the spacing between them and DNA sequence to certain extent. Furthermore, 
the spectroscopic effects of chemical modification on Nap and DNA incorporation of 
NB-TTP were also evaluated. It was proposed that hydrophobicity/hydrophilicity change 
of Nap could be the reason of the fluorescence wavelength shift and intensity change. 
The self-quenching effect of two NB moieties on the same DNA backbone was also 
observed and such effect could be partially alleviated by dissociating dsDNA into ssDNA. 
Again, the initial DNA sequence (14nt-primer/21-nt template) was almost a random 
choice and modified with minimal changes to have two NB-TTPs incorporated. These 
preliminary proof-of-concept studies could provide valuable and insightful information for 
future rational design of nucleic acid-based boronolectins (NBLs) with intrinsic 
fluorescence change towards carbohydrates, glycoprotiens or glycolipids. 
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5. CELL IMAGING STUDIES USING NB-TTP 
5.1 Introduction 
Inspired by the Hageman’s boronic acid-cell surface labeling studies196-198 and 
encouraged by our group’s success in developing fluorescent diboronic acids 
recognizing sialic acid on tumor cell membrane,142,199 further work to explore the 
potential applications of the synthesized NB-TTP was undertaken. There are several 
considerable advantages of utilizing NB-TTP to label cells. First, the long excitation and 
emission wavelengths (λex: 490nm, λem: 540 nm) of NB-TTP fluorophore avoid the 
potential problems of photodamages and high background noises commonly caused by 
ultraviolet (UV: 200-400 nm) illumination.299-300 Besides, NB-TTP also has very close 
excitation/emmission wavelengths to FITC filter set (495 nm/520 nm), which makes cell 
labeling easily observable under fluorescent microscope. Second, napthalimide-based 
compounds have previously been tested in cancer301-304 and virus infection305-307 therapy, 
and cell-imaging study,308-312 but none of those had boronic acid moieties attached to. 
The success of incorporating boronic acid into cells could provide valuable information 
for other therapeutical research such as living cell glycan detection308 or boron-neutron 
capture therapy (BNCT).162,313-315 Third, with the TTP-moiety attached to the fluorophore, 
we expected that there be the possibility of the DNA duplication machinery of dividing 
cells to incorporate NB-TTP into their genomic sequences, since it is known that NB-TTP 
is recognized as DNA polymerase substrate in in vitro studies.  
However, there are also several issues that need to be taken into consideration 
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before NB-TTP cell labeling experiments. Since the triphosphate group of NB-TTP is 
negatively charged under physiological pH condition, the cell permeability of NB-TTP 
could be a hurdle. Also, the cytotoxicity of NB-TTP is unknown, given the large planar 
structure of the napthalimide moiety is found in anti-cancer reagents.301,303-304 Three 
possible scenarios were expected of the labeling studies: 1) NB-TTP could not enter into 
the cell, but stay outside and label the cell-surface glycans with the boronic acid moiety; 
2) NB-TTP could enter into the cell cytoplasma due to its amphiphilic nature, but could 
not pass the nuclear membrane; 3) NB-TTP could diffuse across both the cellular and 
nuclear membrane, and even accumulate inside the nucleus either through incorporation 
into genomic DNA , intercalation between DNA base through stacking, or simply staining 
chromatin proteins like histone through ionic interactions. All those possible results could 
provide valuable information for further experimental design. In this chapter, HeLa cells 
were chosen as the labeling target of NB-TTP. Nap and boronic acid 9 (Scheme 3.1), 
with no TTP moiety, was used as the control labeling compound. 
 
5.2 Results and discussion 
Nap, NB9 and NB-TTP at various concentrations (50, 25, 12.5, 6.25, 0 μM) were 
added into cell culture medium containing HeLa cells in a 24-well plate with coverslips. 
Coverslips from the wells were taken at different time intervals (2, 5, 9, 17, 24 h), fixed to 
slides and observed under the Zeiss Axiovert 400M inverted epifluorescence microscope 
using FITC filter. From the cell imaging pictures taken (Table 5.1), it was observed that 
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shortly after 2 h of incubation, all compounds (Nap, NB9 and NB-TTP successfully 
labelled HeLa cells. As expected, Nap labeled HeLa in a whole-cell pattern with intense 
fluorescence. This might be because of that Nap has smaller molecular weight and high 
hydrophobicity, which makes it capable of quick diffusing through cellular and nuclear 
membrane into cytoplasma and nuclear area. A comparison of labeling results between 
50 μM (Table 5.1 c and e) and 25 μM (Table 5.1 d and f) suggested a 
concentration-dependent staining pattern. At this stage, however, no clear distinction of 
the labeling style between control (NB9) and NB-TTP could be seen since both 
compounds stained the cells in a homogeneous way and the fluorescence intensities in 
cytoplasm and in nucleus were comparable. After 5 h of incubation, no significant change 
of Nap labeling pattern has been observed, but NB9 seems to accumulate in cytoplasm 
more than in nucleus (Table 5.2 c and d) while NB-TTP still labeled cells in a 
non-selective way (Table 5.2 e and f). After 9 and 17 h, it was clear that the NB9 was 
significantly more localized in the cytoplasm (Table 5.3 c; Table 5.4 c) while the nucleus 
showed much lower fluorescence staining. In contrast, NB-TTP showed much more 
accumulation in the nucleus area with some punctuate-labeling pattern (Table 5.3 e; 
Table 5.4 e). Similar punctuate-labeling pattern was observed with Nap labeling 
consistantly (Table 5.1-5.5 a and b). From the imaging results after 24 h incubation, it 
could be seen that NB-TTP still labeled the cell nucleus with higher fluorescence 
intensity (Table 5.5 b) while control compound showed few surviving cells (Table 5.5 e). 
Besides, it also indicated that NB-TTP was stable enough to last for at least 24 h under 
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cell incubation condition with persistent staining pattern. 
Table 5.1 HeLa cell imaging 2 h after incubation 
[exposure time 2.54s with FITC filter 495/520] 
(a) Nap 50 μM (b) Nap 25 μM 
(c) NB9 50 μM (d) NB9 25 μM 
(e) NB-TTP 50 μM (f) NB-TTP 25 μM 
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Table 5.2 HeLa cell imaging 5 h after incubation 
[exposure time 2.54s with FITC filter 495/520] 
(a) Nap 50 μM (b) Nap 25 μM 
(c) NB9 50 μM (d) NB9 25 μM 
(e) NB-TTP 50 μM (f) NB-TTP 25 μM 
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Table 5.3 HeLa cell imaging 9 h after incubation 
[exposure time 2.54s with FITC filter 495/520] 
(a) Nap 50 μM (b) Nap 25 μM 
(c) NB9 50 μM (d) NB9 25 μM 
(e) NB-TTP 50 μM (f) NB-TTP 25 μM 
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Table 5.4 HeLa cell imaging 17 h after incubation 
[exposure time 2.54s with FITC filter 495/520] 
 (a) Nap 50 μM (b) Nap 25 μM 
(c) NB9 50 μM (d) NB9 25 μM 
(e) NB-TTP 50 μM (f) NB-TTP 25 μM 
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Table 5.5 HeLa cell imaging 24 h after incubation 
[exposure time 2.54s with FITC filter 495/520] 
(a) Nap 50 μM (b) Nap 25 μM 
(c) NB9 50 μM (d) NB9 25 μM 
(e) NB-TTP 50 μM (f) NB-TTP 25 μM 
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As an overview of the cell imaging profiles of Nap, NB9 and NB-TTP, it can be 
concluded that labeling was a concentration- and time-dependent process for NB9 and 
NB-TTP, while Nap showed quick and consistant labeling pattern with no significant 
difference between two used concentrations. Initially, good membrane permeability of 
Nap allowed it to diffuse into the cell cytoplasm and nucleus area quickly and uniformly. 
For the less hydrophobic NB9 and NB-TTP, their permeability and diffusion rate was 
much slower than Nap. Thus, it took longer time for NB9 and NB-TTP to develop each 
labeling-pattern.  Since the triphosphate group of NB-TTP is highly hydrophilic, the 
napthalimide moiety probably contributes significant hydrophobicity to grant the 
amphiphilic molecule enough lipid solubility. As the incubation time increased, NB-TTP 
showed a better preference for cell nucleus accumulation while control was primarily 
localized at cytoplasm area. Since the major difference between NB-TTP and control is 
the thymidine triphosphate moiety, one plausible way to explain the labeling behavior 
difference could be the selective incorporation of NB-TTP as a TTP analogue by DNA 
duplication machinery during the cell mitosis process. However, further experiment 
shows that the extracted genomic DNA from NB-TTP-labeled HeLa cell had little 
fluorescence (Figure 5.1 a) compared with the crude protein precipitation fraction (Figure 
5.1 b). The NB9-labeled cell fractions showed similar result. Thus, the HeLa nucleus 
could be stained through other mechanisms, e.g. ionic interactions between negatively 
charged NB-TTP with positively charged histones, which could also explain the 
punctuate-labeling pattern in some labeled cells (Table 5.3 e). Because the NB-TTP 
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penetration into the nucleus was not a major problem, there could be an enhanced 
chance for NB-TTP incorporation into genomic DNA by suppressing the natural TTP 
level, such as addition of thymidylate synthase inhibitor, e.g. Raltitrexed. To further 
confirm that NB-TTP indeed labeled the cell nucleus, HeLa cell nuclei isolation was 
performed according to published protocol.254 Obviously, bright rounded nucleus could 
be seen from the NB-TTP-labeled cells extraction (Figure 5.2 b), while the 
control-labeled cells didn’t show such (Figure 5.2 a). 
 
(a) (b) 
Figure 5.1 Fluorescence measurement of HeLa cell lyses fractions 
 (λex: 490 nm, in 0.1 M pH 8.0 phosphate buffer) 
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(a) NB9 (b) NB-TTP 
Figure 5.2 HeLa cell nuclei isolation [exposure time: 2.54s with FITC filter 495/520] 
 
5.3 Conclusion 
In conclusion, the synthesized NB-TTP has been found to be cell nucleus- labeling 
fluorescent reagent with good cell-membrane permeability. Compared with the control 
(boronic acid 9), NB-TTP showed significant accumulation inside cell nucleus area. The 
HeLa cell culture was consistently stained by NB-TTP up to 50 μM for at least 24 h. Even 
though the detailed labeling mechanism was still unclear, the experiment served as a 
good starting point for the design and synthesis of cell imaging reagent using a similar 
strategy. Furthermore, the successful demonstration of the feasibility of incorporating 
boronic acid into living cells may even provide some insight into in vivo carbohydrate 
detection and distribution study in the future. 
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6. MAJOR FINDINGS, SIGNIFICANCES, POTENTIAL APPLICATIONS AND 
FURTHER IMPROVEMENTS 
  The major contribution of the work in this dissertation was the successful synthesis of 
a naphthalimide-based boronic acid-modified TTP (NB-TTP). The challenges in the 
multiple synthetic steps lay in the instability of the boronic acid (towards light, air, heat, 
pH and metal ions) and the triphosphate product (towards heat and pH). In addition, the 
high polarity of both boronic acid and triphosphate compounds made them very hard to 
purify. It was only through careful handling of all materials and design of the synthetic 
strategy, together with condition optimization after trial and error that the desired final 
product (NB-TTP) was obtained. It was accomplished in a total of 13 steps to yield the 
final product of MW > 1kD. 
  The signicance of NB-TTP was its intrinsic longwavelength fluorescence intensity 
increase upon carbohydrate binding. It was surprising to find that after conjugation of NB 
towards TTP and incorporation of NB-TTP into DNA sequence, the fluorescence 
intensity and quantum yield of NB was further increased, rather than being quenched. 
The binding studies of NB-DNA with fructose indicated that it is the very first example of 
modified DNA showing intrinsic fluorescent changes upon sugar binding and such 
changes do not rely on FRET. Thus, it was forseeable that NB-based fluorescent DNA 
sensors could be developed through appropriately selected DNA sequences or scaffolds 
with high affinity and selectivity towards specific glycan. The beauty of this new type of 
sensor is that the binding signal is increased fluorescenct intensity at a visible 
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wavelength, which made observation and recording convenient.  
  Besides its potential application in DNA-based sensor development, NB-TTP might 
also be used in fluorescent cell imaging. From the HeLa cell imaging results, it seemed 
that the boronic acid moiety of NB prevent it from entering the nuclear area as comared 
with Nap. In contrast, NB-TTP showed significant accumulation in cell nucleus. The cell 
lysis fractionation results suggested that the labeling pattern of NB-TTP was not resulting 
from genomic DNA incorporation, which might be due to the large molecular size and 
cytotoxic effect of NB. Despite of that, it certainly opened the door of the possibility that 
by choosing a smaller boronic acid moiety with less cytotoxic effect, a new B-TTP may 
function as the probe for changes in the nuclear environment, nuclear imaging, and cell 
division genomic DNA tracing. 
  In all, the work accomplished was a systematic preliminary study of fluorescent 
boronic acid modified nucleic acid’s potential applications. Further exploration in this field 
might require more efforts in developing an improved version of NB-TTP, which should 
demonstrate better water solubility, higher fluorescence intensity, higher quantum yield, 
more obivious fluorescence changes upon analyte binding, etc. In order to do that, 
careful selection of a new boronic acid moiety is required. This boronic acid should meet 
the previously described criteria. The same rule also applies to cell imaging applications 
of boronic acid-modified nucleic acid. 
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APPENDIX:    NMR and MS Spectra  
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17:14:0605-Jun-200950%MeOH+0.5%NH3
m/z
160 180 200 220 240 260 280 300 320 340 360 380 400 420 440 460 480 500 520 540 560 580 600
%
0
100
XIAOCHUAN_YXC_E_ESI_NEG_WANG_060509 151 (2.805) 1: TOF MS ES- 
543430.3
211.1
162.1
189.0
329.2
315.2
225.1
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17:22:5605-Jun-200950%MeOH+0.5%NH3  LeuEnk as ITSD 554.2615 Da  
m/z
400 410 420 430 440 450 460 470 480 490 500 510 520 530 540 550 560 570 580 590 600
%
0
100
XIAOCHUAN_YXC_E_ACCUMASS_ESI_NEG_WANG_060509 53 (0.982) AM (Cen,3, 80.00, Ar,6500.0,554.26,0.00); Cm (50:53) 1: TOF MS ES- 
2.07e3*;554.2615
430.1778
446.1496 463.1687
576.2299
570.2365 585.2595
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15:00:1805-Jun-2009100%MeOH+0.1%HCOOH 
m/z
200 220 240 260 280 300 320 340 360 380 400 420 440 460 480 500 520 540 560 580 600 620 640 660 680 700
%
0
100
XIAOCHUANG_YXC_F_ESI_POS_WANG_060509 65 (1.208) Cm (64:65) 1: TOF MS ES+ 
691546.4
214.2 349.3
244.3
237.2
338.5
279.3
296.1
317.3
371.3
387.4
404.4
459.3
486.3
619.5
600.5
565.9
680.6
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15:34:2405-Jun-2009100%MeOH+0.1%HCOOH LeuEnk as ITSD 556.2771Da
m/z
554 556 558 560 562 564 566 568 570 572 574 576 578 580 582 584 586 588 590 592 594 596 598 600 602 604 606 608 610
%
0
100
XIAOCHUANG_YXC_F_ACCUMASS_ESI_POS_WANG_060509 4 (0.074) AM (Cen,3, 80.00, Ar,6500.0,556.28,0.00); Cm (4:6) 1: TOF MS ES+ 
2.20e3*;556.2771
554.2644
602.1453
600.1504
578.2465
572.3964
562.0283 568.2701 575.8451
584.2573
580.3134 590.4286 594.2209
610.1913
 
 
130 
 
 
15:57:3305-Jun-200950%MeOH+0.5%NH3
m/z
260 280 300 320 340 360 380 400 420 440 460 480 500 520 540 560 580 600 620 640 660 680 700
%
0
100
XIAOCHUANG_YXC_G_ESI_NEG_WANG_060509 44 (0.817) Cm (40:45) 1: TOF MS ES- 
1.42e3564.3
546.3
536.3
463.2
578.3
592.4
608.3
642.3622.3
 
 
131 
 
 
16:00:1205-Jun-200950%MeOH+0.5%NH3  LeuEnk as ITSD 554.2615 Da  
m/z
500 505 510 515 520 525 530 535 540 545 550 555 560 565 570 575 580 585 590 595 600 605 610 615 620 625 630 635 640 645 650
%
0
100
XIAOCHUANG_YXC_G_ACCUMASS_ESI_NEG_WANG_060509 96 (1.782) AM (Cen,3, 80.00, Ar,6500.0,554.26,0.00); Cm (81:96) 1: TOF MS ES- 
3.58e4564.2310
*
554.2615
546.2229
536.2195
578.2449
592.2562
608.2239
636.2438622.2375
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16:21:0905-Jun-200950%MeOH+0.5%NH3 
m/z
260 280 300 320 340 360 380 400 420 440 460 480 500 520 540 560 580 600 620 640 660 680 700
%
0
100
XIAOCHUANG_YXC_H_ESI_NEG_WANG_060509 191 (3.551) Cm (181:191) 1: TOF MS ES- 
2.14e3492.3
478.3
464.3
385.0
289.0
265.0
273.0 357.0333.0303.0
317.0
366.9
446.3
425.0
393.0
560.3
508.3
522.3 542.3 574.3
592.4 634.3 660.4
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16:36:0805-Jun-200950%MeOH+0.5%NH3 LeuEnk as ITSD 554.2615 Da  
m/z
455 460 465 470 475 480 485 490 495 500 505 510 515 520 525 530 535 540 545 550 555 560 565 570 575 580 585 590
%
0
100
XIAOCHUANG_YXC_H_ACCUMASS_ESI_NEG_WANG_060509 153 (2.840) AM (Cen,3, 80.00, Ar,6500.0,554.26,0.00); Cm (147:153) 1: TOF MS ES- 
3.31e3*;554.2615
464.1796
478.2029
492.2142
576.2440
560.1657
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16:11:5005-Jun-200950%MeOH+0.5%NH3 
m/z
260 280 300 320 340 360 380 400 420 440 460 480 500 520 540 560 580 600 620 640 660 680 700
%
0
100
XIAOCHUANG_YXC_I_ESI_NEG_WANG_060509 31 (0.574) Cm (28:32) 1: TOF MS ES- 
381547.3
270.9
286.9
299.9
529.3351.0
316.9
335.0
519.3366.9 457.2388.9 429.2404.9 492.3472.9 508.3
538.3
561.3
575.3
591.3
605.3
625.3 647.3 669.3
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16:09:1805-Jun-200950%MeOH+0.5%NH3 LeuEnk as ITSD 554.2615 Da  
m/z
536 538 540 542 544 546 548 550 552 554 556 558 560 562 564 566 568 570 572 574 576 578 580 582 584 586
%
0
100
XIAOCHUANG_YXC_I_ACCUMASS_ESI_NEG_WANG_060509 7 (0.130) AM (Cen,3, 80.00, Ar,6500.0,554.26,0.00); Cm (4:8) 1: TOF MS ES- 
4.76e3547.1912
538.1747
561.2071
*
554.2615
552.2035
575.2200
564.2220
566.2409
568.2050
580.2385
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16:30:46in 50%MeOH
m/z
1000 1010 1020 1030 1040 1050 1060 1070 1080 1090 1100 1110 1120 1130 1140 1150 1160 1170 1180 1190 1200
%
0
100
YXC_III_81_ESI_NEG_WANG_040308 487 (4.818) Cm (452:490) TOF MS ES- 
1.54e31032.3
1031.3
1024.4
1014.3
1033.3
1054.3
1034.3
1040.3
1050.3
1112.3
1055.3
1111.31056.3
1070.3
1134.31113.3
1120.3 1133.3
1135.3
1142.3 1150.2
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16:20:0011-Aug-200950%MeOH+50%H2O+0.5%NH3, Naformate as standard
m/z
900 950 1000 1050 1100 1150 1200 1250 1300 1350 1400 1450 1500 1550
%
0
100
XIAOCHUAN_YXC_N_TTP_ESI_NEG_WANG_081109_04 194 (3.598) AM (Cen,3, 80.00, Ar,6500.0,1064.81,0.00); Sm (SG, 2x3.00); Cm (97:199) 1: TOF MS ES- 
3.23e31032.2321
952.2639
928.8410
974.2462
996.8255
1054.2092
1134.1755
1112.1940
1076.1965 1156.1544
1200.7742
1336.72851268.7655
1404.6814
1370.7089
1472.6542
1452.6578
1540.5889
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